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The hemagglutinin-neuraminidase (HN) protein of Newcastle disease virus 
(NDV) is an important multifunctional envelope protein, which plays key roles in virus 
attachment, neuraminidase and fusion promotion activities. Using the established reverse 
genetics technique for the recovery of infectious NDV from cloned cDNA, the role of the 
HN protein in NDV pathogenesis was explored. By exchanging the HN gene between an 
avirulent NDV strain LaSota and a virulent NDV strain Beaudette C (BC), two chimeric 
viruses were generated. In vitro and in vivo studies done with the chimeras indicated an 
important role of the HN protein in modulating NDV virulence in hosts.  
 
  
The HN gene of NDV has six glycosylation sites, two of which are not used for 
addition of carbohydrates. The exact role of the four functional glycosylation sites in 
NDV pathogenesis is unknown. To understand the importance of these sites in 
influencing NDV virulence, each site was eliminated individually and in combination on 
a cDNA clone of NDV strain BC. Four single mutant viruses with each of the sites (1-4) 
and one double mutant virus with sites 1 and 2 eliminated, were recovered. Results from 
this study established the key role of glycosylation site 4 and glycosylation sites 1 and 2 
in combination, in influencing NDV pathogenesis.  
 
A recent crystal structure of the HN protein of NDV gives valuable information 
about the location of amino acids involved in receptor-binding, neuraminidase and fusion 
promotion activities of the protein. To study the effect of mutagenesis of such key amino 
acids on NDV pathogenesis in vivo, five recombinant viruses with mutations in residues 
at the receptor-binding domains of the HN protein and in residues differing between the 
LaSota and BC strains of NDV, were generated. In vitro and in vivo studies with these 
viruses indicated the important role of certain residues in viral infectivity.  
 
In summary, the importance of the HN protein in NDV pathogenesis was 
established. Further studies indicated the role of glycosylation sites in modulating NDV 
virulence. The relevance of certain key amino acid residues on the HN protein in NDV 
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1.1  Title 
 
General Introduction  
 
1.2  Introduction 
 
 Newcastle disease is a highly contagious and fatal viral disease that affects all 
species of birds. The clinical signs seen in birds affected by this disease vary widely and 
are dependent on factors like the virus strain, host species and age, immune status, 
environmental stress and presence of other organisms. In chickens, the disease may vary 
from sudden death with 100% mortality to subclinical disease  (2). The disease has a 
worldwide distribution, and is a major threat to the poultry industries due to the huge 
economic loss associated with it.  
 
 Newcastle disease is caused by the Newcastle disease virus (NDV), which has 
been categorized into three main pathotypes depending on the severity of the disease in 
chickens: the lentogenic, mesogenic and velogenic strains. Lentogenic strains are 
avirulent and may cause mild respiratory infection. Mesogenic strains are of intermediate 
virulence and cause respiratory disorders with low mortality. Velogenic strains are highly 
virulent and cause high mortality. Velogenic strains are classified into neurotropic 
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velogenic strains, which cause neurological and respiratory disorders and viscerotropic 
velogenic strains, which cause hemorrhagic lesions in the digestive tract (2).  
 
 NDV is a member of the genus Avulavirus of the family Paramyxoviridae, in the 
order Mononegavirales. (78, 89). This family also includes other important pathogens 
such as the mumps virus, human parainfluenza virus, sendai virus, simian virus 5 and 
recently emerging nipah and hendra viruses. Recently, the nipah virus has been assigned 
as a Category C biological agent for biowarfare/bioterrorism by the Center for Disease 
Control (50). The velogenic strains of NDV have also been identified as potential animal 
pathogens which may be used as agents for bioterrorism, resulting in huge impacts on the 
a nation’s agricultural economy (51). Thus, it is important to understand the molecular 
basis for pathogenesis of paramyxoviruses and to explore technologies for designing 
alternative safe vaccines for emergency preparedness. 
 
NDV has a single stranded negative-sense RNA genome (89), which is 15,186 
nucleotides long (29, 68, 108). The genomic RNA contains six genes encoding at least 
eight proteins (104, 137). Three proteins which constitute the nucleocapsid are the 
nucleoprotein (NP), the phospoprotein (P), and the large polymerase protein (L). The two 
external envelope proteins are the fusion protein (F) and the hemagglutinin-
neuraminidase protein (HN). The inner layer of the virion is formed by the matrix protein 
(M). The two additional proteins formed by the editing process during P gene 
transcription, are the V and W proteins. NP binds to the genomic RNA forming the 
nucleoapsid core, whereas the P and L proteins are associated with the nucleocapsid core 
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and help in viral transcription and replication. The M protein helps in viral assembly. The 
F protein plays a direct role in the fusion process. It mediates fusion of the viral envelope 
with the host cell membrane, enabling viral entry into the cell membrane. The HN protein 
has functions in attachment, fusion promotion and removal of sialic-acid from progeny 
virions, thus, acting as a neuraminidase. The V protein of NDV functions as an alpha 
interferon antagonist (55).  Function of the W protein is unknown (71, 137). In between 
each gene are short sequences called the intergenic sequences, the functions of which are 
unknown. At the beginning and end of each gene are conserved sequences known as the 
gene start (GS) and gene end (GE) sequences, respectively. These contain signals for 
transcription. The genome of NDV is flanked by a 55 nucleotide (nt) leader region at the 
3' end and a 114 nt trailer region at the 5' end (68). These regions serve as cis-acting 
elements involved in replication and packaging of the viral RNA (71). 
 
The HN protein of NDV plays an important role in virus life cycle. Besides 
playing a role in attachment of the virus to host cells, it cleaves sialic acid receptors from 
viral and cellular surfaces, preventing progeny virus from self-aggregating or adhering to 
cell membranes. HN also promotes cell fusion by interacting with the F protein of NDV. 
Thus, the HN has both hemagglutinating and neuraminidase activities (71). The HN 
protein is a type II glycoprotein possessing six glycosylation sites. Glycosylation in 
proteins helps in protein folding, maturation, stability and influences antigenicity and 
immunogenicity of the protein. While the role of glycosylation on the biological activities 
of the HN glycoprotein has been studied earlier (81), the effect of glycosylation of the 
 3
protein on virus infectivity has not been investigated extensively. It would be interesting 
to find out the role of the functional glycosylation sites of HN on the virulence of NDV.  
 
Although the HN genes of virulent and avirulent NDV strains share a high 
percentage of homology, the viruses differ substantially in their virulence. Since HN is a 
multifunctional protein of NDV, which is actively involved in virus infectivity, studying 
the roles of the HN gene in virus pathogenesis would be important.  By exchanging the 
HN gene between avirulent and virulent NDV strains, its role in pathogenesis could be 
determined.  
 
The HN protein along with the F protein, is also the main target of immune 
response for NDV (82, 87). A recent report by Zeng et al., (152) indicated that the HN 
protein of NDV was responsible for induction of interferon-alpha and tumor necrosis 
factor. Since HN possesses immunogenic properties, studies on this protein may prove to 
be useful for the development of NDV vaccines.  
 
 Reverse genetics is a major breakthrough technique, which allows the production 
of infectious RNA viruses from cloned DNAs. It helps in the manipulation of the 
genomes of negative-sense RNA viruses. Lack of genetic recombination and inability of 
the naked RNA to initiate viral RNA synthesis has hindered genetic manipulation of 
single-stranded, negative sense RNA viruses. Reverse genetics makes it possible to 
introduce genetic changes directly into the negative-stranded RNA virus genomes. It has 
important implications in molecular biology studies and the development of attenuated 
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vaccines. The current vaccination protocol for NDV utilizes live attenuated lentogenic 
strains like the Hitchner B1 (47) and LaSota (42). As encountered in any live attenuated 
vaccine, NDV vaccine may still cause disease signs depending on the environmental 
conditions and stress. A highly stable and efficacious vaccine then becomes a desired 
objective. Using the reverse genetics system, we have investigated the role of the HN 
protein in NDV pathogenesis. We have further studied the importance of glycosylation 
sites in influencing viral infectivity. Additionally, the role of certain key amino acid 
residues of the HN protein involved in hemagglutination, neuraminidase and fusion 
promotion activities of NDV have also been investigated.  
 
1.3  Research objectives 
 
The specific objectives of the present study were: 
1. To understand the role of the HN protein in NDV pathogenesis; 
2. To study the importance of glycosylation sites on the HN protein of NDV and; 
3. To investigate the role of individual key amino acids of HN involved in cell 

















2.1  Title  
 
 
Review of Literature 
 
 
2.2  Classification  
 
  
 NDV is a member of the order Mononegavirales, family Paramyxoviridae, 
subfamily Paramyxovirinae and genus Avulavirus (78, 89). NDV is the only member of 
the genus Avulavirus (78). Other important members of the family Paramyxoviridae are 
the mumps virus, SV5 and parainfluenza virus type 2.  
 
2.3  Virion 
 
The NDV virus particles are pleomorphic in nature and range from 150-400 nm in 
size. The virions contain a long helical nucleocapsid structure which is 1,000 nm long 
and 17-18 nm in diameter. The envelope is covered with spike glycoproteins which are 8-
12 nm in diameter. The genome of NDV is a single strand of RNA of negative sense, and 
has a molecular weight of 5.2 to 5.7 × 106 daltons (2). The genomic RNA consists of 15, 
186 nucleotides (29, 68, 108). The helical nucleocapsid, rather than the free genome 
RNA, is the template for all RNA synthesis. The nucleocapsid protein (NP) and genome 
RNA together form a core structure, to which the phosphoprotein (P) and the large 
polymerase protein (L) are attached (71). This core forms the RNP or the transcriptive-
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replicative complex and serves as the minimum infectious unit. The envelope of NDV 
contains two surface glycoproteins: the hemagglutinin-neuraminidase (HN) protein 
responsible for attachment of the virus to host cells and the fusion (F) protein required for 
fusion of the virus into the host cell membrane (49). The F and HN proteins are also the 
main targets of the immune response of NDV (82, 87). Internal to the envelope is the 
matrix (M) protein, which is thought to be important in viral assembly (105). Fig. 1 
shows a schematic diagram of the NDV and Fig. 2 depicts an electron micrograph of the 
virus particle.  
 
2.4  Genome organization 
 
The NDV genome consists of six genes (3' NP-P-M-F-HN-L 5') encoding at least 
eight proteins (104, 137). The genomic RNA contains a 3' extracistronic region of 55 
nucleotides, known as the leader, and a 5' extracistronic region of 144 nucleotides, known 
as the trailer (68). These regions are essential for replication of the genome, and they 
flank the six genes. At the beginning and end of each gene are conserved transcriptional 
control sequences, known as the gene start and gene end sequences, respectively. 
Between the gene boundaries are intergenic regions, which vary in length from 1- 47 
























Figure 2. Electron micrograph of negatively stained pleomorphic Newcastle disease 
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Figure 3. Genetic map of genomic RNA of NDV. NDV has  a single-stranded, negative-
sense RNA genome which is 15, 186 nucleotides in length. The length of leader, trailer 
and each gene is shown in parantheses. Each gene is flanked by conserved gene start and 
gene end sequences. The intergenic sequences present in between two genes range from 










2.5  Viral proteins 
 
The six genes of NDV code for at least eight proteins: NP, P, M, F, HN, L, V and W. The 
V and W proteins are the two additional proteins formed by non-templated nucleotide 
addition through the RNA editing process during P gene transcription (137). 
 
2.5.1 Nucleocapsid  and its associated proteins 
 
The nucleocapsid protein (NP) and genome RNA together form a core structure, 
to which the phosphoprotein (P) and the large polymerase protein (L) are attached (71). 
These three proteins form the transcriptive-replicative complex, which is the minimum 
infectious unit of NDV.  
 
NP protein: The NP protein serves several functions in viral replication, 
including encapsidation of the genome RNA into a nucleocapsid (the template for RNA 
synthesis), association with the P-L polymerase during transcription and replication and 
most likely, interaction with the M protein during virus assembly. The intracellular 
concentration of unassembled NP is also considered to be a major factor controlling the 
relative rates of transcription and replication from genome templates (7, 8). The NP gene 
of NDV consists of 1747 nucleotides with a coding region of 489 residues.  The 
molecular weight of the protein is predicted to be 54 kilodaltons (kD) (68). 
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P protein: The P gene of NDV is 1451 nt long. The P gene ORF encodes an 
unedited version of mRNA, which results in formation of the P protein. RNA editing with 
the addition of one G nucleotide at the editing site (near the center of the ORF) produces 
an mRNA which encodes the V protein, whereas addition of two G nucleotides produces 
an mRNA that encodes the W protein.  (71,137). The P protein is essential for viral RNA 
synthesis. This protein is highly phosphorylated in nature. It is an essential component of 
the viral RNA polymerase and the nascent chain assembly complex formed during viral 
RNA synthesis. The P protein associates with the L protein forming the viral polymerase 
(P-L) and thus, functions as a transcriptive and replicative factor. It also associates with 
the unassembled NP (NP0) forming the P- NP0 complex (44). This property of P protein 
has been suggested to prevent NP0 from assembling RNA non-specifically (77). The 
predicted molecular mass of the polypeptide is 53 kD (27). 
 
L protein: The L protein is the least abundant of the structural proteins (about 50 
copies per virion). The L-gene is the most promoter-distal in the transcription map and 
thus the last to be transcribed. Its low abundance, its large size and its localization to 
transcriptionally active viral cores suggested that it might be the viral polymerase. The P 
and L proteins form a complex, and both proteins are required for polymerase activity 
with NP:RNA templates (26, 44, 76). The L protein is also responsible for capping and 
polyadenylation of the mRNAs. Polyadenylation is thought to result from polymerase 
stuttering on a short stretch of U residues. The L gene is 6704 nt long. The predicted 
molecular mass of the polypeptide is 242 kD (151).  
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2.5.2    Matrix Protein 
M is the most abundant protein in the virion. The M gene of NDV is 1241 
nt long. Its predicted molecular mass is 40 kD (14). The M protein interacts with the 
nucleocapsid and the envelope proteins of the virion. This protein is considered to be the 
central organizer of viral morphogenesis, interacting with the cytoplasmic tails of the 
integral membrane proteins, the lipid bilayer, and the nucleocapsids. The self-association 
of M and its contact with the nucleocapsid may be the driving force in forming a budding 
virus particle (105). 
 
2.5.3   Envelope glycoproteins 
 
NDV possesses two integral membrane glycoproteins namely, the hemagglutinin-
neuraminidase (HN) glycoprotein which is involved in cell attachment and the fusion (F) 
glycoprotein which mediates pH-independent fusion of the viral envelope with the 
plasma membrane of the host cell.  
 
HN protein: The HN glycoprotein of NDV is a multifunctional protein and a 
major antigenic determinant of the virus. It is responsible for the adsorption of the virus 
to sialic acid-containing receptors. In addition, HN mediates enzymatic cleavage of sialic 
acid (neuraminidase activity) from the surface of virions and the surface of infected cells. 
In addition to the hemagglutinating and neuraminidase activities, HN also has a fusion 
promoting activity, through interacting with the fusion glycoprotein of NDV (71). 
Previous research has indicated that for fusion to occur, a type-specific interaction 
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between the F and HN proteins is required. It is proposed that HN undergoes a 
conformational change on attachment to its ligand and thereby triggers a conformational 
change in the F protein to release the fusion peptide (70). Studies have shown that a point 
mutation in the globular domain of HN that abolishes its receptor recognition, 
neuraminidase and fusion activities, also interferes with its ability to interact with F (32). 
Research on the role of the HN protein in the mechanism of cell membrane fusion 
indicate that the binding of the HN protein to the receptor induces conformational 
changes of residues near the hydrophobic surface of the protein and this change in turn, 
triggers the activation of the F protein, which initiates membrane fusion (140). The HN 
gene is 1998 nt long with a coding region having 577 amino acid residues. The HN of 
some strains of NDV is synthesized as a biologically inactive precursor (HN0), and 90 
residues from the C-terminal are removed to activate the molecule (83, 84, 94). The HN 
proteins are type II integral membrane proteins that span the membrane once. The N-
terminus of the HN protein consists of the cytoplasmic domain, followed by the 
transmembrane region and the stalk region. The protein contains a single hydrophobic 
domain, located near the N-terminus, that acts as a combined signal and anchorage 
domain targeting the nascent chain as it emerges from the ribosome to the membrane of 
the endoplasmic reticulum and ensuring the translocation of the polypeptide chain across 
the membrane, bringing about the stable anchoring of the protein in the lipid bilayer (71). 
The C-terminus end of the protein is composed of the globular head or the ectodomain. 
This region of the HN protein is the main site of attachment of the virus to host cells. The 
HN glycoprotein of NDV contains six N-linked carbohydrate chains (81). These 
carbohydrate chains are added to the protein in the rough endoplasmic reticulum as it 
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undergoes modifications in various cell compartments during its formation (67).  All but 
one of the six glycosylation sites on the HN protein, are located in the C-terminal external 
domain. The secondary structure prediction shows that the C-terminal external domain is 
mostly arranged in beta-sheets, while alpha-helices are predominantly located in the N-
terminal domain of the protein (118). The predicted molecular weight of the HN protein 
is 74 kD (12). The HN protein forms an oligomer consisting of di-sulfide linked 
homodimers that form a non-covalently linked tetramer (75). There has been debate for 
many years as to whether the HN molecules contain combined or separate active sites for 
hemagglutinating and neuraminidase activities. Recent studies and analysis of the crystal 
structure of HN of NDV have predicted that there resides a single site in the HN protein 
that binds sialic acid tightly (hemagglutination activity), but hydrolyses the molecule 
slowly (neuraminidase activity) (24).  
 
F protein: The F protein of NDV mediates viral penetration by fusion between 
the virion envelope and the host cell plasma membrane, in a pH-independent manner. 
After fusion, the nucleocapsid is delivered to the cytoplasm. Later in infection, the F 
protein expressed at the plasma membrane of infected cells can mediate fusion with 
neighboring cells to form syncytia (giant cells). Syncytia formation is a hallmark of NDV 
infection in host cells. It is a typical cytopathic effect caused by the virus and can lead to 
tissue necrosis and might also be a mechanism of virus spread. The F protein is a type I 
integral membrane protein and is synthesized as an inactive precursor (F0) that is cleaved 
by a host-cell protease. This cleavage releases a new N-terminus of F1, thus forming the 
biologically active protein, consisting of disufide-linked chains F1 and F2 (122). The 
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cleavage of F0 is a key determinant for pathogenicity of paramyxoviruses. Viruses that 
have multiple basic residues in the cleavage site of the F protein have proteolytic 
cleavage of the F0 molecule intracellularly by subtilisin-like proteases such as, furin, 
during transport of the protein through the trans Golgi network.  Paramyxoviruses that 
have single basic proteins in the F cleavage site cannot be cleaved intracellularly and 
require exogenous proteases for cleavage activation (102, 122). The F gene is 1792 nt 
long. F0 has a predicted molecular mass of 66 kD. F1 is 55 kD and F2 is 12.5 kD (13). The 
fusion peptides are thought to intercalate into target membranes, starting the fusion 
process.  
 
2.6   Stages of replication of NDV 
 
All aspects of replication of NDV occur in the cytoplasm. In cell-culture,  
single-cycle growth curves  for virulent NDV strains can be as short as 10 hours. During 
the late stages of infection, the effect of viral replication can result in complete shut off of 
host macromolecular synthesis. Initiation of infection starts with the adsorption of the 
virus to the cell receptors and subsequent fusion into host cellular membrane. Finally, 
progeny viruses mature by budding through the plasma membrane. Cleavage of the F0 
precursor glycoprotein to F1 and F2 by host cell proteases is required for progeny virus to 





2.6.1 Virus adsorption and entry 
Molecules containing sialic acid serve as cell surface receptors for NDV. Sialic 
acid is found both on glycoproteins and on lipids making NDV accessible to a wide range 
of host cell receptors. Upon adsorption of the virus to the cellular receptors, the viral 
membrane fuses with the host cellular plasma membrane at neutral pH. This results the 
release of the viral nucleocapsids into the cytoplasm of the host cell. The M protein is 
considered to make several contacts with the nucleocapsid. After the release of the 
nucleocapsid into the cytoplasm, disruption of the M-nucleocapsid complex is necessary. 
The driving force for this process is unknown in paramyxoviruses.  
 
2.6.2 Transcription 
All viral mRNA synthesis begins at the 3΄ end of the genome of NDV. The cis-
acting promoter sequences function as initiators of leader RNAs and the antigenome. The 
viral RNA polymerase has to first transcribe the leader RNA before beginning mRNA 
synthesis at the NP gene start signal. RNA replication of Sendai virus requires the 
genome length to be a multiple of six (“Rule of Six” theory), for efficient replication 
(10). NDV also follows the rule of six principle for efficient replication. This hexamer 
rule is most likely related to the finding that each NP subunit of the nucleocapsid is 
associated with exactly six nucleotides  (37). The efficiency of the promoter at the 3΄ end 
depends on its position relative to the NP subunits. Apart from sendai virus, the rule is 
important for RNA replication in PIV3, SV5 and measles (35, 90, 133); but not in RSV 
(120). Once the nucleocapsid is released in to host cell cytoplasm the leader mRNA is 
synthesized first, on entry of the NP and P/L polymerase at the 3΄ end of the genome. The 
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leader sequence contains the regulatory elements needed for gene expression. After 
synthesis of the leader RNA, reinitiation begins at the gene start of the first gene (NP) 
and terminates at the gene end. This results in release of the first capped and 
polyadenylated mRNA (147). Transcription continues in this start-stop manner until the L 
mRNA is synthesized. The intergenic regions located in between the genes are not 
transcribed. Initiation of a downstream mRNA depends on termination of the upstream 
mRNA consistent with a single viral RNA polymerase entry site at the 3΄ end of the 
genome.  The frequency with which the viral RNA polymerase reinitiates the next mRNA 
at gene junctions is not perfect. This leads to a gradient of mRNA abundance that reduces 
according to the distance of the location of a particular gene from the 3΄ end of the 
genome (11).  
 
2.6.3 Replication 
The (-) genome replicates via a full-length complementary copy known as the 
antigenome (+). After translation of the primary transcripts and accumulation of the viral 
proteins, antigenome synthesis begins. The (-) genome is then synthesized by making a 
complementary copy of the antigenome. During this process, the viral RNA polymerase 
which was engaged in mRNA synthesis till now, copies the same genomic template, but 
this time, ignores all the junctional signals, and synthesizes an exact complementary copy 
(7, 93). Both the genome and antigenome are assembled into encapsidated nucleocapsid. 
The leader and trailer regions of the genome contain specific sequences for initiating 
encapsidation (7). The processes of transcription and replication are tightly regulated. 
When unassembled NP is limiting, the viral RNA polymerase is preferentially engaged in 
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mRNA synthesis, raising the intracellular levels of unassembled NP and all other viral 
proteins. When unassembled NP levels are sufficient, some viral RNA polymerase 
activity switches from transcription to replication, thereby lowering the levels of 
unassembled NP, as each initiation of encapsidation utilizes many NP monomers to finish 
the assembled genome chain (66). The RNA synthesis of NDV is shown in Fig. 4A.  
 
2.6.4 Virus assembly and release 
The intracellular site of nucleocapsid assembly is in the cytoplasm. The first step 
in viral assembly is the encapsidation of genomic RNA into nucleocapsid. The 
nucleocapsids are thought to be assembled in two steps: first, there is an association of 
free NP subunits with the genome or template RNA to form the helical ribonucleoprotein 
(RNP) structure, followed by the association of the P-L protein complex (64). In contrast 
to the antigenomes, Paramyxovirus mRNAs are not encapsidated. The assembly of the 
viral envelope takes place at the cell surface. The viral integral membrane glycoproteins 
(F and HN) are synthesized in the endoplasmic reticulum and undergo step-wise 
conformational maturation before transport through the secretory pathway. Folding and 
maturation of the glycoproteins of NDV occur in the cell with the help of many folding 
enzymes and molecular chaperones. Only correctly folded and assembled proteins are 
transported out of the endoplasmic reticulum. In the Golgi apparatus, the carbohydrate 
chains on the HN glycoproteins are modified extensively. Cleavage of the F proteins with 
multiple basic cleavage sites, occurs in the trans Golgi apparatus. Finally, the 
glycoproteins are transported to the plasma membrane (33). In NDV, the assembly of the 
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envelope occurs at the cell surface and release of the virus takes place by budding (38). 
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Figure 4A.  Paramyxovirus RNA synthesis: schematic representation. Genome and 
antigenome are shown as nucleocapsids with ovals representing the NP subunits and 
vertical lines representing the gene junctions. Capped (triangles) and polyadenylated (zig 
zag lines) are formed by the viral polymerase protein during transcription. These in turn 
are translated into the respective proteins (squiggly lines). (Figure modified from Collins, 
et al., 1996. Respiratory Syncytial virus, In Fields, B.N. Knipe, D. M. and Howley, P. M. 







Figure 4B. The life cycle of NDV. (Figure from review article by Yusoff, K., and W. S. 








The mechanism of viral assembly at the cell membrane is not known. The viral M 
proteins are thought to play a major role in bringing the assembled ribonucleoprotein core 
to the appropriate place on the plasma membrane to form a budding virion (105). It is 
believed that the F and HN glycoprotein cytoplasmic tails make important contacts with 
the M protein, which, in turn, associates with the nucleocapsid. The assembled patch at 
the plasma membrane is then release by budding. 
 
2.7   Reverse genetics 
 
 Reverse genetics is a technique that allows the generation of viruses possessing a 
genome derived from cloned cDNAs. When compared to the positive-sense RNA viruses, 
genome manipulation of negative-sense RNA viruses is more cumbersome. This is 
because the negative-sense RNA viruses require the virion RNA to be assembled into an 
active transcriptase-replicase complex for the genome to initiate viral infection. After 
many years of research, the techniques to manipulate the genomes of nonsegmented 
negative-strand RNA viruses have now been developed (116). This was first done with 
the successful recovery of the rabies virus in 1994 (126). Rabies virus was rescued when 
plasmids encoding the N, P and L proteins, as well as a plasmid coding the entire 
antigenome, all under the control of the bacteriophage T7 RNA polymerase promoter, 
were transfected into cells infected with a recombinant vaccinia virus expressing the 
bacteriophage T7 RNA polymerase protein. 
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Rescue of the rabies virus using reverse genetics procedures was followed by 
recovery of several other viruses such as the vesicular stomatitis virus (73, 149), SV5 
(45), human respiratory syncitial virus (21), Sendai virus (40, 62), rinderpest virus (6), 
parainfluenza virus (36, 48) and measles virus (113).  Reverse genetics systems to 
recover infectious NDV from cloned cDNAs were first reported in 1999 (98, 106). 
Currently reverse genetics systems are available for lentogenic strains LaSota (54, 98, 
106), B1 (95) and for mesogenic strain Beaudette C (69).  The availability of reverse 
genetics technology for NDV and other RNA viruses have provided means to genetically 
define and study these viruses. The reverse genetics technique for the rescue of NDV is 


































 INFECTIOUS NDV 
 
Figure 5.  Schematic procedure for the recovery of infectious NDV (Beaudette C) from 
cDNA. Intracellular expression of antigenomic full-length cDNA (p+NDV) and 
polymerase complex NP, P and L mRNAs encoded in plasmids were co-transfected into 
HEp-2 cells. All the plasmids under the control of the T7 RNA polymerase promoter 
sequence were  transcribed by the T7 RNA polymerase, supplied by the recombinant 
vaccinia MVA/T7 strain. Infectious NDV was generated entirely from cloned cDNA with 
















The hemagglutinin-neuraminidase (HN) protein of NDV plays a crucial role in the 
process of infection. However, the exact contribution of the HN gene in NDV 
pathogenesis is not known.  In this study, the role of the HN gene in NDV virulence was 
examined.  Using reverse genetics procedures, the HN gene was exchanged between a 
virulent recombinant NDV strain, rBeaudette C (rBC), and an avirulent recombinant 
NDV strain, rLaSota. The hemadsorption and neuraminidase activities of the chimeric 
viruses showed significant differences from their parental strains, but heterotypic F and 
HN pairs were equally effective in fusion promotion. The tissue tropism of the viruses 
was shown to be dependent on the origin of the HN protein. Chimeric virus with the HN 
protein derived from the virulent virus exhibited tissue predilection to that of virulent 
virus and vice versa. The chimeric viruses with reciprocal HN proteins either gained or 
lost virulence, determined by standard intracerebral pathogenicity index test in chickens 
and mean death time in chicken embryos devised to classify these viruses, indicating that 
virulence is a function of the amino acid differences in the HN protein. These results are 
consistent with the hypothesis that virulence of NDV is multigenic, and cleavability of F 






Newcastle disease virus (NDV), the only member of the genus Avulavirus, belongs to 
the family Paramyxoviridae (78). NDV is an important pathogen of many species of 
birds, which invokes trade barriers and causes significant economic losses in the 
commercial poultry industry worldwide.  NDV isolates display a spectrum of virulence in 
chickens which vary from a fatal to an inapparent infection (2). Strains of NDV are 
classified into three major pathotypes, depending upon the severity of disease produced 
in chickens. Avirulent strains are termed lentogenic; intermediately virulent strains are 
termed mesogenic, and highly virulent strains are termed velogenic. 
 
The surface of NDV particles contains two important functional glycoproteins; fusion 
(F) and hemagglutinin-neuraminidase (HN) proteins. In general, membrane glycoproteins 
drive the assembly and budding of enveloped RNA viruses (134), and are the key players 
in determining the host range and tissue tropism. The F protein mediates both virus-cell 
and cell-cell fusion (46). The F protein is synthesized as a non-fusogenic precursor, F0, 
and only becomes fusogenic after cleavage by host cell proteases into disulfide-linked F1 
and F2 polypeptides (117). The cleavability of F protein is directly related to the 
virulence of viruses in vivo. A high content of basic amino acid residues at the F0 
cleavage site is correlated to virulence (17, 148). Recent studies with recombinant NDV 
generated by reverse genetics techniques showed that modification of a lentogenic F 
cleavage site into a velogenic cleavage site increased the virulence of the strain (103, 
106), but did not reach the virulence level of velogenic strains. This result indicated that 
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the efficiency of cleavage of the F0 protein is not the sole determinant responsible for the 
virulence of NDV. 
 
  The HN protein of NDV is a multifunctional protein. It possesses both the 
receptor recognition and neuraminidase activities associated with the virus. It recognizes 
sialic acid-containing receptors on cell surfaces; it promotes the fusion activity of the F 
protein, thereby allowing the virus to penetrate the cell surface; and it acts as a 
neuraminidase by removing the sialic acid from progeny virus particles to prevent 
progeny viral self-agglutination (71). Thus, HN protein plays an important role in viral 
infection. Although the functions of the HN protein in NDV infection are well studied, its 
role in NDV pathogenesis is presently not known. We have recently shown that the 
cleavability of F protein alone does not convert an otherwise non-pathogenic strain into a 
highly virulent pathotype (103). Other gene products of NDV may also be involved in 
imparting virulence to a strain. 
 
In this study, we exchanged the HN gene between a virulent recombinant NDV 
strain rBeaudette C (rBC) and an avirulent recombinant NDV strain rLaSota, thus, 
generating chimeric recombinant NDV viruses,  rBC LaSoHN and rLaSo BCHN. Here, 
we show that the HN gene-swapped viruses were viable, and their tropism and virulence 
were altered depending on the nature of the HN gene sequence. The rBC LaSoHN virus 
showed reduced virulence, while the rLaSo BCHN virus showed an increase in virulence. 
The rBC and and rLaSo BCHN viruses were distributed systemically in chicken embryos,  
while the rLaSota and rBC LaSoHN viruses remained in the respiratory tract and never 
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reached systemic sites.  These altered pathogenic properties evidenced by the  
exchange of the HN gene indicate its essential role in the tropism and virulence of NDV. 
 
3.4 Materials and Methods  
 
3.4.1 Cells and Viruses 
DF1 cells (a chicken embryo fibroblast cell line) were maintained in DMEM, and 
Vero and HEp2 cells were maintained in EMEM media, with 5% fetal bovine serum 
(FBS). NDV strains, LaSota and BC were received from the National Veterinary Services 
Laboratory, Ames, IA. They were propagated in the allantoic cavity of embryonated 
chicken eggs. After two days, the allantoic fluid was harvested and the virus was purified 
(103). Briefly, the allantoic fluid was harvested and clarified by low speed centrifugation 
at 1800 × g for 30 min. Virus was pelleted by ultracentrifugation  at 35, 000 × g for 18 h 
and the pelleted virus was resuspended in 4 ml sterile PBS. The virus was then layered on 
top of a discontinuous sucrose gradient made with 3 ml of 55% and 5 ml of 20% sucrose 
in PBS. The gradient was then ultracentrifuged at 43, 000 × g for 1 h. The virus band at 
the interface of the 20% and 55% sucrose gradients was collected and pelleted at 35, 000 
× g for 18 h. The virus pellet was resuspended in 500 µl of PBS and stored at 4oC.  
 
3.4.2 Construction of plasmids and recovery of chimeric viruses 
Full-length antigenomic cDNAs of BC and LaSota strains of NDV, designated as 
pBC and pLaSota respectively, were cloned into a low-copy number plasmid vector 
pBR322. These cDNA clones were used to rescue the retcombinant viruses, rBC and 
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rLaSota respectively, as described elsewhere (54, 69). A chimeric rBC virus containing 
LaSota HN gene in place of its own, and the reciprocal recombinant rLaSota virus 
containing BC HN gene, were generated for this study (Fig.6). The unique MluI and AgeI 
sites in pBC and MluI and SnaBI sites in pLaSota at the F-HN and HN-L intergenic 
regions were exploited for exchanging the HN genes between the full-length plasmids. 
The LaSota HN gene was amplified by PCR using MluI (+) primer:  
5′ AACTACGCGTTGTAGATGACCAAAGGACGATATACGGGTAG 3′ and 
AgeI (-) primer:  
5′ GATCACCGGTACGTATTTTGCCTTGTATCTCATTGCCACTTAC 3′. The BC HN 
gene was amplified using the MluI (+) primer described above and Sna BI (-) primer:  
5′ GATCTACGTATTTTGCCTTGTATCTCATTGCCACTTAC 3′. The resulting full-
length clones were designated as pBC LaSoHN and pLaSo BCHN, respectively. These 
plasmids were used to recover the recombinant chimeric viruses, rBC LaSo HN and 
rLaSo BCHN, using reverse genetics procedures (69).  
 
Full-length antigenomic cDNAs of LaSota and BC viruses were cloned into a 
low-copy number plasmid vector, pBR322 (54, 69). They were designated as pBC and 
pLaSota, respectively. Reverse genetics procedures were used to rescue the recombinant 
viruses (rLaSota and rBC), as described elsewhere (54, 69). A chimeric rBC virus 
infectious clone containing LaSota HN gene in place of its own, and the reciprocal 
recombinant consisting of rLaSota infectious clone bearing the Beaudette C HN gene, 
were generated (Fig.6). In pBC, the unique MluI site in the intergenic region of F and HN 
genes and the unique AgeI site in the intergenic region of HN and L genes were used to 
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exchange the HN genes between rBC and rLaSota virus infectious clones.  PCR was done 
using LaSo MluI (+) primer:  
5′ AACTACGCGTTGTAGATGACCAAAGGACGATATACGGGTAG 3′ and 
LaSo AgeI (-) primer:  
5′ GATCACCGGTACGTATTTTGCCTTGTATCTCATTGCCACTTAC 3′ 
which created overhangs of MluI and AgeI sequences flanking the pLaSota HN gene. The 
HN gene from the full-length pBC plasmid was removed by digesting the full-length pBC 
plasmid with MluI and AgeI enzymes. The resulting full-length plasmid of pBC∆ 
HN was then ligated with the pLaSota HN gene PCR product, after digestion with MluI 
and AgeI enzymes, to obtain the full-length pBC LaSo HN plasmid.  In pLaSota, the 
unique MluI site in the intergenic region of F and HN genes and the unique SnaBI site in 
the intergenic region of HN and L genes were used to exchange the HN genes between 
rBC and rLaSota infectious clones.  For the insertion of the HN gene of pBC into 
pLaSota, PCR was done with the full-length pBC plasmid using primers flanking its HN 
gene. Primers used were: BC MluI (+) primer:  
5′ AACTACGCGTTGTAGATGACCAAAGGACGATATACGGGTAG 3′ 
and BC Sna BI (-) primer:  
5′ GATCACCGGTACGTATTTTGCCTTGTATCTCATTGCCACTTAC 3′ 
These primers introduced overhangs of MluI and SnaBI sites at the beginning and end of 
the pBC HN gene, respectively. The PCR product was then digested with MluI and  
Sna BI enzymes and ligated to the full-length pLaSota to obtain pLaSo BC HN plasmid. 
These plasmids were used in the recovery of the recombinant chimeric viruses, rBC LaSo 
HN and rLaSo BCHN respectively, using reverse genetics procedures (69).  
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fragment between the rBC and rLaSota viruses, using Mlu I and Age I and Mlu I  and Sna 
B I sites, respectively. The first and last nucleotide of the entire full-length genome of the 






















3.4.3 RNA extraction and RT-PCR of recovered chimeric viruses 
The recovered recombinant chimeric viruses rBC LaSoHN and rLaSo BCHN 
were grown in the allantoic cavity of 9-day-old embryonated chicken eggs. After 2 days, 
the allantoic fluid was harvested, clarified and the virus was purified as described above. 
Viral RNA was extracted from the recovered viruses using TRIzol (Invitrogen) according 
to the manufacturer’s instructions. Reverse transcription was done with the extracted 
RNA, using the Thermoscript RT kit (Invitrogen) to synthesize the first strand cDNA. 
The genomes of recovered chimeric viruses were entirely sequenced after RT-PCR to 
confirm the presence of the substituted gene. The sequence of the forward and reverse 
primers used for the RT-PCR of the substituted LaSota HN gene in the BC genome were: 
5′AACTACGCGTTGTAGATGACCAAAGGACGATATACGGGTAG 3′  
and 5′GATCACCGGTACGTATTTTGCCTTGTATCTCATTGCCACTTAC 3′ 
respectively. Forward and reverse primers used for the RT-PCR of the HN gene of pBC 
in the LaSota genome were:  
5′AACTACGCGTTGTAGATGACCAAAGGACGATATACGGGTAG 3′ and  
5′ GATCACCGGTACGTATTTTGCCTTGTATCTCATTGCCACTTAC 3′ respectively.  
 
3.4.4 Growth characteristics of viruses 
The growth kinetics of rBC LaSoHN and rLaSo BCHN were performed by 
multiple-cycle growth conditions in DF1 cells. Virus was inoculated at an MOI of 0.01 to 
DF1 cells grown in DMEM with 5% FBS at 37oC. The medium of cells infected with 
rLaSo BCHN contained 1 µg/mL of acetyl trypsin.  Supernatant was collected at 8 h 
intervals until 56 h post-infection (P.I). The virus content in the samples was quantitated 
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by plaque assays in DF 1 cells. Briefly, supernatant, collected from virus-inoculated 
samples earlier, was serially diluted, and 100µl of each serial dilution was added per well 
of confluent DF1 cells. After 60 min adsorption, cells were overlaid with DMEM 
(containing 2% FBS and 0.9% methyl cellulose), and incubated at 37oC for 3-4 days. The 
cells were then fixed with ethanol and stained with crystal violet for enumeration of 
plaques.  
 
             3.4.5 Neuraminidase assay 
A fluorescence-based neuraminidase (NA) assay was done as described by Potier 
et al. (110). Briefly, serial two-fold dilutions of virus samples were prepared in 50 µl 
volumes of enzyme buffer (32.5 ml of 0.1 2-N-Morpholinoethanesulfonic acid [MES], 
pH 6.5 and 4.0 ml of 0.1M calcium chloride made up to a final volume of 100 ml with 
Milli-Q water) in a 96-well plate. Ten µl of 12.5% v/v dimethyl sulfoxide (DMSO) was 
added to all wells of an assay plate (black 96-well Microfluor plates, Franklin, MA). Ten 
µl of each virus dilution was transferred in duplicate (2 rows) to the assay plate, starting 
with the most dilute in column 11. Ten µl of enzyme buffer alone was added to each well 
of column 12 (blank wells). The reaction was initiated by the addition of 30 µl per well of 
substrate mix (1 volume of 325 mM MES, pH 6.4, 3 volumes of 10 mM calcium chloride 
and 2 volumes of 0.5mM 2’-(4-methylumbelliferyl)- α-D-N-acetylneuraminic acid 
[MUN] (Sigma) to give a final concentration in the assay of 100 µM MUN. The reaction 
was incubated at 37oC for 15 min with shaking, and terminated by the addition of 150 µl 
per well of 0.014 M sodium hydroxide in 83% (v/v) ethanol. NA activity of the recovered 
viruses was measured with the 4-methylumbelliferone released from the fluoregenic 
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substrate, MUN. Released 4-methylumbelliferone was quantified by fluorometric 
determination with an excitation wavelength of 360 nm and emission wavelength of 450 
nm. Readings from the substrate blanks were subtracted from the virus sample readings, 
and the mean values of duplicate readings calculated.  
 
3.4.6 Hemadsorption (HAd) assay 
Virus was inoculated to confluent monolayers of Vero cells in 6-well plates at an 
MOI of 10. After 18 to 24h, the media was decanted and the cells were overlaid with 
guinea pig RBCs in PBS at a concentration of 1 × 108 cells/ml. The plates were kept at 
4ºC for 15 min. The unbound RBCs were removed by washing twice with PBS. The 
RBCs bound to the virus-infected cells were lysed with 0.05 M ammonium chloride and 
the released hemoglobin was measured at 549 nm in a spectrophotometer.   
 
3.4.7 Fusion Index assay 
  The fusogenic abilities of the recombinant viruses were examined as described by 
Kohn (65). Virus was inoculated to confluent (1X106cells/ml) Vero cells in 6-well plates 
at an MOI of 0.1. Cells were maintained in 5% DMEM medium at 370C and 5% CO2. 
After observing CPE within 48-72 h, media was removed and cells were washed once 
with 0.02% EDTA and then incubated with 1 ml of EDTA for 2 min at room temperature. 
The cells were then washed with PBS and fixed with methanol for 20 min at room 
temperature. Staining of the cells was done with hematoxylin-eosin (HE) stain (Hema 3). 
Quantitation of fusion was done by expressing the fusion index as the ratio of total 
number of nuclei to the number of cells in which these nuclei were observed (i.e., the 
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mean number of nuclei per cell). The NA, HAd and fusion index values of all viruses 
were expressed as a percentage of these values compared to the wild-type virus, rBC, in 
which these values were considered to be 100 per cent. 
 
3.4.8 Immunohistochemistry  
The tissue tropism of recombinant NDV was examined in 9-11-day-old 
embryonated chicken eggs. Briefly, 103 PFU of each of the recombinant NDV was 
inoculated into developing chicken embryos by the chorio-allantoic route. The infected 
embryos were chilled at 48 h PI, and tissues such as spleen, kidney, small intestine, large 
intestine, lung, heart, and brain were collected and fixed for cryosectioning and 
processing as described by Sheela et al., (132). The tissues were cryosectioned and 3-5-
umeter sections were cut for immunohistochemistry. All sampled tissues were examined 
by immunohistochemistry using the following protocol to detect the viral HN protein 
(IHC/HN). The sections were rehydrated in three changes of PBS, 10 min each, followed 
by treatment with proteinase K (10 ug/mL) for 30 min at 37oC. The sections were then 
washed three times with PBS, fixed with ice-cold acetone and washed again in PBS. To 
quench endogenous peroxides, the sections were flooded with 0.3% hydrogen peroxide in 
methanol for 30 min at room temperature. After washing with three changes of PBS at 
10-min intervals, the tissues were blocked with normal horse serum (VectaStain kit, 
Vector Laboratories, Burlingame, CA) for 30 min. The sections were then incubated with 
a 1: 500 dilution of the primary NDV monoclonal antibody (72) cocktail against HN 
(10D11, AVS, 15C4 and B79) for 1h at room temperature. After washing, sections were 
incubated with VectaStain secondary antibody (Vector Laboratories, Burlingame, CA) 
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for 30 min, as recommended by the manufacturer. After a further washing cycle, the 
sections were incubated with VectaStain ABC reagent for 30 min. Substrate was 
NovaRed (Vector Laboratories, Burlingame, CA). Sections were counterstained lightly 
with hematoxylin and coverslipped with Vectamount (Vector Laboratories, Burlingame, 
CA) for a permanent record. 
 
3.4.9 Mean Death Time (MDT) in chicken embryos 
  The virulence of the recovered viruses was determined by the mean death time in 
embryonated SPF chicken eggs (1). A series of 10-fold dilutions of infected allantoic 
fluid was made in sterile PBS, and 0.1 ml of each dilution was inoculated into the 
allantoic cavity of each of the five 9-day old embryonated eggs. The eggs were incubated 
at 37oC and examined four times daily for 7 days. The time that each embryo was first 
observed dead was recorded. The highest dilution at which all embryos died was 
considered the minimum lethal dose. The MDT was recorded as the mean death time in 
hours for the minimum lethal dose to kill the embryos. The MDT has been used to 
classify NDV strains into velogenic (taking under 60 h to kill); mesogenic (taking 
between 60 h to 90 h to kill) and lentogenic (taking more than 90 h to kill).  
 
3.4.10 Pathogenicity studies in chickens 
  To test the pathogenicity of the recovered viruses in vivo, intra cerebral 
pathogenicity index (ICPI) test was performed according to standard procedures (1). For 
ICPI, 103 PFU/ chicken of each virus was inoculated intracerebrally into groups of ten 1-
day-old specific-pathogen-free (SPF) chicks. The inoculation was done using a 27-guage 
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needle attached to a 1 ml stepper syringe dispenser that was set to dispense 0.05 ml of 
inoculum per inoculation. The birds were inoculated by inserting the needle up to the hub 
into the right or left rear quadrant of the cranium. The birds were observed for clinical 
symptoms and mortality once every 12 h for a period of 8 days. Equal numbers of 
chickens were used in each experiment. Each experiment had mock-inoculated controls 
that received a similar volume of sterile PBS by the respective routes. The ICPI values 
were calculated as described by Alexander (1). Briefly, the birds were scored daily: 0 if 
normal, 1 if sick, and 2 if dead. The ICPI value was the mean score per bird per 
observation. Highly virulent (velogenic) viruses give values approaching 2; avirulent 
(lentogenic) viruses give values close to 0. To assess the survivability rates of birds 
inoculated with the recombinant viruses, one-day-old chicks were inoculated 
intracerebrally with 103pfu/chick. Infected chicks were observed daily for 8 days for 





3.5.1 Recovery of recombinant parental and chimeric NDV 
The recovery of recombinant NDV from infectious cDNA clones, derived from a 
mesogenic strain of NDV, BC, and a lentogenic NDV strain, LaSota, have been reported 
earlier from our laboratory (54, 69). We used the established reverse genetics system to 
examine the role of the HN gene in the virulence of NDV, in this study. The HN genes of 
an avirulent recombinant NDV virus rLaSota and a virulent NDV virus were exchanged 
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in an otherwise identical genomic background. To ensure the presence of the intended 
HN gene swaps, the entire cDNA clone of each chimeric virus was sequenced using Big 
dye terminator (Applied Biosystems) method.  The supernatants from transfected HEp2 
cells were passaged two times in DF1 cells to recover infectious NDV. Virus-positive 
supernatants were used to inoculate the allantoic cavities of 9-11-day-old embryonated 
SPF eggs. The allantoic fluid harvested after embryo deaths were analyzed in a 
hemagglutination (HA) assay. Allantoic fluid with a positive HA titer was used for the 
isolation of viral RNA, followed by a sequence analysis of an RT-PCR fragment that 
covered the HN gene swap region. Nucleotide sequencing confirmed that the introduced 
HN gene exchanges between rBC LaSoHN and rLaSo BCHN were retained in the 
recovered viruses. The recovered rBC virus bearing the LaSota HN gene in place of its 
own HN gene was called rBC LaSoHN virus, and rLaSota virus with its HN gene 
replaced by the HN gene of BC virus was designated as rLaSo BCHN.  These exchanges 
were stable and were seen even after 5 sequential passages of these viruses at high MOI 
in DF1 cells and in 9-day-old embryonated chicken eggs (data not shown). 
  
3.5.2 Growth of the recombinant viruses in vitro 
The growth characteristics of the parental and chimeric viruses were assessed by 
multi-step growth curves (Fig.7). The differences in the growth kinetics of HN gene swap 
viruses were marked until 16 h PI. When compared to its parental rLaSota virus, the 
growth rate of rLaSo BCHN virus was more than two-fold higher at 16 h PI, while the 
rBC LaSoHN virus was 1.4-fold lower than its parental rBC virus. The parental and gene 
swap viruses grew to similar titers after 32 h PI. These studies showed the relevance of 
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HN in virus growth in vitro. No differences were observed in the plaque sizes of 
recombinant viruses with reciprocal HN swap viruses when compared to their parental 
viruses. These results indicated that heterotypic F and HN proteins were compatible in 




























































Figure 7.  The growth kinetics of parental and chimeric viruses in chicken embryo 
fibroblast (DF1) cells. Multiple cycle growth conditions were employed to assess the 
differences in the growth of these viruses. DF 1 cells were infected with each of these 
viruses at an MOI of 0.01. Supernatants collected at 8h intervals were used for 
determining the virus titers by a plaque assay.  The values represented are the means from 







3.5.3 Biological activities of mutant viruses 
We analyzed whether the origin of HN protein determines the biological activities 
of NDV. The NA, HAd and fusion activities of the parental and chimeric viruses are 
shown (Fig.8).  The percent biological activity of each chimeric or parental virus is 
shown relative to the rBC virus, whose biological activities were considered to be 100%. 
The NA and HAd values of rBC LaSoHN was only 50% of the parental rBC virus, while 
there was an 80 % increase in the HAd and a 20 % increase in the NA values of rLaSo 
BCHN virus over the rLaSota virus.  The fusogenic abilities of the parental and chimeric 
viruses did not vary significantly. These studies reiterate the importance of HN protein in 
the attachment and neuraminidase functions of NDV in the context of a viral infection. 
These differences in the attachment and elution may translate into differences in viral 
growth kinetics in vivo. Furthermore, these results demonstrate that a combination of F 


















































































Figure 8.  The in vitro biological activities of the parental and HN chimeric viruses. The 
hemadsorption (HAd), neuraminidase (NA) and fusogenicity of the parental and HN 
chimeric viruses were examined. The percent biological activities of these viruses are 
compared to the rBC virus, whose activities were considered to be 100%. The HAd was 
measured as the percentage of the hemoglobin released from guinea pig RBCs attached to 
infected cells. The NA activity of purified parental and chimeric viruses was measured by 
a fluorometric assay. The fusion index (FI) was estimated in Vero cells infected at an 
MOI of 0.1. The cells were stained with H&E stain and the FI was calculated. The FI is 
the ratio of the total number of nuclei to the number of cells in which the nuclei were 
observed, i.e., the mean number of nuclei per cell. The mean of three independent 
experiments is shown.  
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3.5.4 Cytopathogenicity and Tissue tropism 
  The cytopathic effects (CPE) of the HN swap viruses differed significantly. At 48 
h PI, the rLaSo BCHN virus showed more extensive CPE in primary CEF cells than the 
rLaSota virus (Fig. 9). Similarly, rBC LaSoHN virus showed markedly less CPE than the 
rBC virus. The rapid destruction of cell monolayers by the rLaSo BCHN virus was 
consistent with the increase in the receptor recognition and neuraminidase activities of 
the virus. In the rBC LaSoHN virus, the reduction in the receptor binding and NA 
activities may have resulted in the differential CPE observed in CEF cells.  
 
On the other hand, the tissue distribution of the chimeric viruses after chorio-
allantoic inoculation of 10-day-old chicken embryos showed that the HN protein 
probably determines tissue tropism. The chimeric rBC LaSoHN and the lentogenic 
rLaSota viruses did not reach the brain of inoculated embryos, while with the rBC and 
rLaSo BCHN viruses, NDV-specific antigen could be demonstrated in different parts of 
the brain. (Fig.10). NDV antigens were localized in the alveolar epithelium and 
peribronchiolar space with rBC and rLaSo BCHN viruses, while chicken embryos 
inoculated with rLaSota and rBC LaSoHN viruses showed discrete staining of the 
bronchial and bronchiolar epithelium. The rLaSota and rBC LaSoHN viruses were also 
distributed in the villous epithelial cells of the small and large intestines, in addition to 
the lungs. There was a wide dissemination of the rBC and rLaSo BCHN viruses in 
chicken embryonic tissues such as lung, brain, kidney, intestines and spleen. The extent 
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Figure 9.  The cytopathogenicity of the parental and chimeric viruses in DF1 cells. The 
cells were infected at an MOI of 0.1with each of these viruses. After 24 and 48h, the 
cyotopathic effects (CPE) of each virus infected monolayer was examined under an 
inverted microscope. The differences in the CPE of each virus infected monolayer at 24 
and 48h are shown. The figures in top panel represent CPE observed at 24h post-
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Figure 10.  The tissue tropism of recombinant NDV in developing chicken embryos. 
Groups of 9-11-day-old chicken embryos were inoculated with 103 PFU  of each of the 
parental and HN chimeric NDV by the chorio-allantoic route. Frozen sections from 
infected embryos were processed for immunohistochemistry after 48 h. Tissue sections 
were stained with primary NDV monoclonal antibody cocktail followed by VectaStain 
(Vector Laboratories) and VectaStain ABC reagent. The substrate was NovaRed (Vector 
Laboratories). Representative sections from each virus infected embryo are shown. While 
rLaSota and rBC-LaSoHN viruses showed no staining in the cerebellum (A and B), the 
cerebellum showed extensive antigen-specific staining in the molecular layer in rLaSo-
BCHN virus (C), Viral antigens were localized in the bronchial and bronchiolar 
epithelium with rLaSota (D) or rBC-LaSoHN (E) viruses, but diffuse interstitial staining 
was noticed with rLaSo-BCHN virus (F). Magnification Χ 20.  
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3.5.5 Pathogenicity studies of mutant viruses 
  We wished to determine whether the differences in in vitro biological 
characteristics of the chimeric viruses would translate into increased or decreased 
virulence in chickens or chicken embryos. The MDT of rLaSo BCHN was decreased to 
84 h when compared to the parental rLaSota virus, which had a MDT of 96 h, indicating 
an enhancement in the virulence of the chimeric virus. The rBC virus had a MDT of 62h 
while rBC LaSoHN took 72h to kill embryonated SPF eggs, indicating the degree of 
attenuation imparted by the LaSoHN to the rBC genetic background. The ICPI values 
indicated altered virulence properties in chimeric viruses when compared to the parental 
viruses (Table 1). The recombinant rLaSo BCHN had an ICPI of 0.75 when compared to 
its lentogenic parental strain rLaSota with an ICPI of 0.00, despite both of them being 
isogenic, except for the swapped HN gene. The rBC LaSoHN virus, on the other hand, 
showed a reduced ICPI value of 1.02 when compared to its mesogenic parental virus rBC 
with an ICPI of 1.58. The survivability of 1-day-old chicks inoculated intracerebrally 
with the recombinant viruses is shown (Fig.11). The rLaSota virus induced 0% mortality 
after 8 days of inoculation. The rLaSo BCHN virus showed a dramatic increase in 
virulence compared to its parent rLaSota, with only 20% of the birds surviving on day 8. 
After inoculation with rBC virus, 20% of the birds survived on day 3 and by day 4, all the 
inoculated birds were dead. On the contrary, the rBC LaSoHN virus showed decreased 
virulence compared to its parent rBC, with 20% of the birds surviving on day 5 and 100% 
mortality on day 6. The gain or loss of virulence in these viruses, therefore, appears to be 
solely mediated by the HN gene. 
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The virulence of the mutant and parental viruses was evaluated by intracerebral 
pathogenicity index (ICPI) in day-old-chicks, and minimum death time (MDT) in 
embryonated chicken eggs. a ICPI was determined by inoculating 103 PFU of each virus/ 
bird, into groups of 10 one-day-old SPF chicks, via the intracerebral route. The birds 
were observed daily for 8 days and at each observation, scored 0 if normal, 1 if sick, and 
2 if dead. The ICPI value is the mean score per bird per observation. Highly virulent 
viruses give values approaching 2 and avirulent viruses give values approaching 0.  b 
MDT in hours for the minimum lethal dose to kill 9-day-old embryonated chicken eggs 
by allantoic route of inoculation. Highly virulent viruses take under 60h to kill the 


























Figure 11.  The survivability of 1-day-old chicks inoculated with the parental and HN 
chimeric viruses. Specific-pathogen-free 1-day-old chicks were inoculated intracerebrally 
with 103 PFU/chick.  Infected chicks were observed daily for 8 days for signs of paralysis 











The HN gene plays an important role in the pathogenesis of paramyxoviruses 
(34).  The HN gene of NDV is a multifunctional protein with receptor recognition, 
neuraminidase activity on sialic acid-containing receptors, and fusion promotion (71). 
Transfection studies with HN mutants of NDV have highlighted the importance of the 
different regions of the HN protein in the biological activities of the protein (31, 80, 81). 
However, the contribution of the HN gene in NDV pathogenesis in the context of virus 
infection is not known. In this study, using reverse genetics techniques, a chimeric rBC 
virus (a recombinant moderately virulent, mesogenic NDV strain) containing the LaSota 
(a recombinant avirulent, lentogenic NDV strain) HN gene in place of its own and the 
reciprocal recombinant, consisting of rLaSota bearing the BC HN gene, were generated 
to assess the effect of HN gene substitution on viral pathogenesis.  The hypothesis tested 
in the present study was that differences in biological functions of HN protein displayed 
by different strains of NDV in vitro are important determinants of pathogenesis in vivo. 
The pathogenicity of the chimeric NDV was examined in the natural host, chicken. The 
results of this study indicated that the in vitro biological characteristics of the HN are 
good indicators of in vivo pathogenicity and the HN gene makes an important 
contribution to the overall virulence of NDV isolates.  
 
The sequence analysis of the chimeric viruses confirmed the presence of the 
substituted HN gene. These chimeric viruses reached similar titers with similar kinetics, 
compared to those viruses with homologous proteins. This suggested that heterologous 
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pairs of HN and F proteins were fully functional despite being derived from different 
viruses. This probably reflects the high level of amino acid sequence identity between 
these two different NDV strains (98.4% in F and 97.1% in HN). The BC and LaSota 
strains used in this study are phylogenetically closely related (15). Therefore, it would be 
interesting to examine whether the HN and F protein pairs derived from distantly-related 
NDV strains, are also functional in vitro and in vivo.   
 
In vitro studies with these viruses yielded results that supported the hypothesis of 
the importance of the HN gene in NDV virulence. The parental rBC virus showed higher 
HAd and NA activities, compared to that of the parental rLaSota virus. Interestingly, the 
rLaSo BCHN virus also had increased HAd and NA activities when compared to its 
parent rLaSota. These activities were decreased in the rBC LaSoHN virus when 
compared to the parental rBC virus. These results indicated that the magnitude of the 
HAd and NA activities of NDV are solely determined by the amino acid differences in 
the HN protein. The fusion promotion activity of HN appeared to be independent of HAd 
and NA activities. Despite the fact that the HAd and NA activities of BC and LaSota 
viruses were at different levels, the heterotypic HN proteins in the chimeric viruses were 
fully functional in fusion promotion. Our results are in agreement with those of Sergel et. 
al., (129) who have shown that the fusion promotion activity of HN did not correlate with 
the level of NA activity.  
 
Several reports have suggested that a type-specific functional interaction between 
F and HN proteins of paramyxoviruses is required for cell fusion (32, 53, 138). Studies of 
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hybrid HN proteins by three different laboratories have all implicated the membrane-
proximal ectodomain in virus-specific fusion promotion activity (31, 141, 144). With this 
approach, the specificity of the NDV F protein has been mapped to amino acids 55-141 
of the NDV HN protein, a sequence adjacent to the HN protein transmembrane domain 
(31). However, we have demonstrated that chimeric NDV containing heterotypic F and 
HN proteins were compatible, since they were derived from phylogenetically closely-
related virus strains (15). It was suggested that a specific interaction occurs between the F 
protein HR2 domain and the HN protein domain from amino acids 124 to 152 for fusion 
promotion (43). There was only one amino acid difference from phenylalanine to tyrosine 
(F132I) between BC and LaSota viruses in the proposed F and HN interacting domain, 
which may be the reason for the heterotypic interaction of the F and HN proteins from 
distantly-related strains of NDV.  
 
It has been proposed that for influenza virus, the neuraminidase activity may be 
important for removing respiratory tract mucin sialic acids, allowing the virus to reach 
target cells (22). There is a precedent for decreased virulence as a result of decreased 
neuraminidase activity for influenza viruses in animals (91, 145). To the contrary, the C-
28 variant of human parainfluenza virus with deficient neuraminidase caused more 
intense disease in cotton rats (111). Examination of a temperature-sensitive NDV variant 
and two sequential revertant viruses revealed that alterations in neuraminidase can 
compensate for alterations in binding (131, 136). The original NDV variant, with an 
amino acid substitution at position 129, was deficient in binding erythrocytes; a second 
mutation, at position 175, reduced neuraminidase activity but restored binding; the third 
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sequential mutation, at position 193, partially restored neuraminidase activity. Thus, the 
balance between the receptor binding and neuraminidase activities appear to be critical to 
the virulence of NDV.   The early induction of CPE in CEF cells by rLaSo BCHN and 
diminished CPE of rBC LaSoHN, when compared to their parental types with 
homologous HN in our study, might have resulted from these changes in receptor 
recognition and NA activities. Increased attachment and NA activities are consistent with 
the early growth and CPE of these viruses with virulent HN as against those viruses 
containing avirulent HN showing a delay in reaching the peak titers and inducing CPE.  
 
A small amino acid motif in the fusion protein precursor [F0], termed the 
cleavage site, has been identified as a pathotype determinant. Thus, viruses with 
multibasic amino acids at the cleavage site are designated virulent, and those 
characterized by monobasic amino acids at the cleavage site are avirulent (17, 18, 19, 20). 
Cleavage of F0 polypeptides into F2 and F1 is essential for a virus particle to become 
infectious (92).  In chickens, the F protein of pathogenic NDV is cleaved by ubiquitous 
intracellular furin-like proteases, and the F protein of non-pathogenic viruses is only 
cleaved by trypsin-like proteases secreted from a limited number of tissues (39). Thus, 
virulent viruses can spread rapidly throughout the host and cause disease. In comparison, 
the avirulent motif can be cleaved only in the respiratory tract and gut, where trypsin-like 
proteases are available. The replication of these viruses is, therefore, restricted to these 
organs (92). However, in our studies with chicken embryos, where F proteins with either 
mono or multibasic amino acids at the cleavage site are cleaved with equal efficiency due 
to the availability of trypsin-like proteases, the HN gene sequence appears to determine 
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the tropism of the virus to different tissues and organs. Especially, the discrete replication 
of viruses with avirulent HN in bronchial and bronchiolar epithelium, widespread 
distribution of the viruses with virulent HN in the lung parenchyma, and the systemic 
distribution of the viruses with virulent type HN in several organs including the brain, 
indicates that the HN protein, independent of F protein cleavability, determines the viral 
tropism in chicken embryos. This may be the result of differences in the receptor 
recognition and NA activities between the HN proteins of BC and LaSota viruses. It 
would be interesting to study the tropism of these viruses in chickens, where F 
cleavability may play a major role in virulence via natural routes of infection.  A set of 
carefully-defined mutations in the HN protein may indicate the amino acid residues 
involved in the tropism and virulence of NDV.  
 
The pathogenicity of the chimeric viruses was assessed by ICPI and MDT tests.  
Interestingly, the results showed that the chimeric rBC virus bearing the HN gene of 
LaSota (the rBC LaSoHN virus) was markedly less virulent than the parental rBC virus, 
and the reciprocal chimeric rLaSo BCHN virus was also mildly virulent, compared to its 
parental rLaSota virus. Chicks inoculated with rLaSo BCHN had lower survival rates,  
compared to chicks inoculated with rLaSota, and chicks inoculated with rBC LaSoHN 
had higher survivability than the ones inoculated with rBC. MDT results also showed a 
gain of virulence of rLaSo BCHN and a loss of virulence of rBC LaSoHN, compared to 
rLaSota and rBC, respectively. Thus, when the HN gene of avirulent LaSota strain 
replaces the HN gene of virulent BC strain in the BC virus, there was a reduction in 
virulence of the chimeric virus (rBC LaSoHN). Exactly, the opposite effect was observed 
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in the chimeric virus, rLaSo BCHN, with enhanced virulence. This “gain or loss of 
function” between the chimeric and parental virus strains was a further indication that the 
observed differences were associated with the HN protein.  
 
In summary, using reciprocal HN gene swaps between avirulent and virulent 
NDV in an otherwise identical genetic background, we have demonstrated that the 
reduced receptor recognition and neuraminidase activities, inherent to avirulent HN, 
translate into differences in the tropism and virulence of the virus. Avirulent HN bearing 
chimeric virus remain restricted in growth to limited tissues and organs, besides being 
attenuated in virulence relative to the parental type. On the other hand, virulent HN 
imparted ability to spread systemically, and enhanced the virulence of an otherwise 
avirulent NDV.  
 
It will be interesting to study the molecular mechanism by which the HN gene 
determines tropism and virulence. The terminal globular head of the HN protein contains 
the active sites involved in virus attachment and neuraminidase activities (24, 57, 58, 86, 
150). Recent results suggest that a specific interaction between the F protein HR2 domain 
and the HN protein membrane-proximal ectodomain spanning amino acids 124 to 152 
occurs for fusion promotion (43). There are only 17 amino acid differences between the 
HN proteins of BC and LaSota viruses. With the availability of an established reverse 
genetics system for avirulent and virulent NDV strains, it would be of special interest to 
mutate these residues on the HN protein involved in its biological functions and observe 








4.1  Title 
 
 
Loss of carbohydrate from the Hemagglutinin-Neuraminidase protein of 
Newcastle Disease Virus affects virulence 
 
 
4.2  Abstract 
 
 
The hemagglutinin-neuraminidase (HN) protein of Newcastle disease virus 
(NDV) is an important determinant of its virulence. Using reverse genetics procedures, 
we investigated the role of each of the four functional N-linked glycosylation sites (G1-
G4) of the HN glycoprotein of NDV on its pathogenicity. The N-linked glycosylation 
sites G1-G4 at residues 119, 341, 433 and 481, respectively, of a virulent NDV strain 
Beaudette C (BC) were eliminated individually by site-directed mutagenesis on a full-
length cDNA clone of BC. A double mutant was also created by eliminating the first and 
second glycosylation sites at residues119 and 341(G12), respectively. Infectious virus 
was recovered from each of the cDNA clones of the HN glycoprotein mutants, employing 
a reverse genetics technique.  The G4 and G12 mutant viruses replicated to lower titers 
than the parental virus. The differences in the biological activities of the mutant viruses, 
such as neuraminidase and hemadsorption activities, were negligible in comparison to the 
parental virus. However, the fusogenicity of glycosylation mutant G4 was significantly 
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lower and that of the double mutant virus (G12) was significantly higher than that of the 
parental virus. Cell surface expression of the G4 virus was significantly lower than the 
parental virus. The antigenic reactivities of the mutants to a panel of monoclonal 
antibodies against the HN protein indicated that removal of glycosylation from the HN 
protein increased (G1, G3 and G12) or decreased (G2 and G4) the formation of antigenic 
sites, depending on their location.  In standard tests devised to assess the virulence of 
these strains, such as the intracerebral and intravenous pathogenicity indices, mutants G4 
and G12 had significantly lower indices than the parental BC virus, indicating loss of 
virulence. These results indicate that glycosylation of the HN glycoprotein of NDV may 
play a role in the virulence of NDV, and that elimination of the fourth glycosylation site 
(residue 481) at the globular head, or more than one glycosylation site (residues 119 and 
341) in the stalk and globular head, may attenuate the virus significantly. This approach 
can be used for the generation of recombinant NDV vaccines. 
 
4.3  Introduction 
 
Newcastle disease virus (NDV) is a member of the family Paramyxoviridae, and 
has been assigned to the genus Avulavirus in the subfamily Paramyxovirinae (78, 89). 
It causes a serious respiratory and neurological disease in all species of birds and is an 
economically-important infectious agent, causing significant losses to the poultry 
industry. Newcastle disease varies in the degree of severity, ranging from an inapparent 
infection to severe disease causing 100% mortality.  NDV strains are categorized into 
three main pathotypes, depending on the severity of disease produced in chickens.  
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Avirulent strains that do not cause disease are known as lentogenic, viruses of 
intermediate virulence that cause respiratory disease are called mesogenic, while 
virulent viruses that cause high mortality are termed velogenic.  Velogenic strains are 
further classified as viscerotropic or neurotropic.  Viscerotropic velogenic strains 
produce lethal infections in which hemorrhagic lesions in the intestine are prominent; 
whereas, neurotropic velogenic strains produce high mortality preceded by neurological 
signs, with the absence of hemorrhagic intestinal lesions (2). 
 
NDV contains a single-stranded, negative sense, non-segmented RNA genome. 
The genomic RNA is 15,186 nucleotides in length (68, 108). The genomic RNA 
contains six genes that encode at least seven proteins (104, 137). The envelope of NDV 
contains two glycoproteins, the hemagglutinin-neuraminidase (HN) and fusion (F) 
proteins. The F glycoprotein mediates fusion of the viral envelope with cellular 
membranes (16). The HN glycoprotein of NDV is a multifunctional protein. It 
recognizes sialic acid- containing receptors on cell surfaces; it promotes the fusion 
activity of F protein of NDV, thereby allowing the virus to penetrate the cell surface, 
and it acts as a neuraminidase by removing the sialic acid from progeny virus particles 
to prevent viral self-aggregation (71).  
 
The HN glycoprotein is a type 2 homotetrameric integral membrane protein 
which undergoes N-linked glycosylation (81, 115). This process occurs in the rough 
endoplasmic reticulum of host cells when an N-linked carbohydrate attaches covalently 
as a core oligosaccharide side chain to asparagines on the nascent polypeptide chain in 
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response to the consensus sequence motif NXT (Asn-X-Thr) or NXS (Asn-X-Ser), 
where X is any amino acid except aspartic acid and proline. The structure of the 
oligosaccharide side chain is then extensively modified as the protein moves through 
the membrane systems of the cell (67). N-linked glycosylation influences many 
properties of glycoproteins, including initiation and maintenance of folding of the 
proteins into their biologically-active conformation, maintenance of protein stability 
and solubility, intracellular transport of the proteins to various subcellular 
compartments and the cell surface, and influencing the antigenicity and 
immunogenicity of the protein (101,112). 
 
The HN glycoprotein sequence of NDV strain Beaudette C (BC) contains six 
predicted sites for addition of N-linked carbohydrates (residues 119, 341, 433, 481, 508 
and 538) (81). A previous study has shown that four of these addition sites (G1, G2, G3 
and G4 at residues 119, 341, 433 and 481, respectively) are used, while two addition 
sites (G5 and G6 at residues 508 and 538, respectively) are not used (81). The same 
study has shown that G1 and G2 play little role in maturation, but modulate the 
biological activities of the protein; whereas, G3 and G4 influence both folding and 
activity of the protein (81). In that study, the role of individual oligosaccharide chains 
in the activities of the HN glycoproteins was examined using a plasmid transfection 
system. Thus, the role of each oligosaccharide chain in viral replication and 
pathogenesis could not be determined. In our current study, a reverse genetics system 
was used to generate recombinant viruses with mutations in the glycosylation sites of 
the HN protein. These mutations eliminated each of the four functional glycosylation 
 59
sites individually (G1, G2, G3 and G4), and in G1 and G2 in combination. This allowed 
the determination of the role played by the individual glycans in the context of viral 
replication and pathogenesis. Our results showed that elimination of the residue at G4, 
and combined elimination of residues at G1 and G2, significantly attenuated the 
pathogenicity of the viruses. It also indicated that G4 played an important role in the 
transport of the HN protein. Interestingly, elimination of G1 and G2 significantly 
increased fusion promotion activities of the viruses. This study provides a useful tool 
for studying the impact of glycosylation of the HN protein of NDV on virus 
pathogenicity, and may be able to provide insights for designing better recombinant 
attenuated NDV vaccines. 
 
4.4 Materials and Methods  
 
4.4.1 Cells and virus 
Chicken embryo fibroblast cell line (DF1) was obtained from Dr. Douglas Foster 
(University of Minnesota) and grown in Dulbecco’s Modified Eagle’s medium (DMEM) 
containing 10% fetal bovine serum. HEp 2 cells, which were used for transfection, were 
grown in Eagle’s minimal essential medium (EMEM) containing 10% fetal bovine 
serum. NDV strain BC and other recombinant viruses were grown in 9-day-old 
embryonated specific-pathogen-free (SPF) chicken eggs. The modified vaccinia Ankara 
(MVA) recombinant that expresses the T7 RNA polymerase (a generous gift of Dr. 





4.4.2 Introduction of HN mutations into full-length NDV cDNA 
Construction of plasmid pNDVfl carrying the full-length cDNA of the NDV 
strain BC has been described previously (69). To introduce mutations into the HN gene 
of pNDVfl, a Age I- Mlu-I fragment containing the HN gene was excised from pNDVfl 
and subcloned into plasmid pGEM-7Z (+) (Promega, Wisconsin, MA). Using appropriate 
oligomers, site-directed mutagenesis (9) was performed on the cDNA clone of the HN 
gene to generate a panel of HN mutants, as shown in Fig. 12. Mutants were named with a 
G (for glycosylation site) and the number of the functional glycosylation site mutated (1-
4). For generating cDNA clone G1, the forward primer used was  
 5′ -6766CAGAACAGCGGGTGGGGGGCACCT 6789-3′ and reverse primer  
5′- 6765 CGCAGCTCCATTAATCTGATAAGAGAG 6739- 3′; for cDNA clone G2, 
forward primer, 5′- 7432 CAGGACACATGCCCAGATGAG 7452-3′ and reverse primer 5′- 
7431GTATCGCTTGTATATTACATATTTCCC 7405-3′; for cDNA clone G3, forward 
primer 5′- 7708CAGAAAACAGCCACTCTTCATAGTCCC 7734-3′ and  reverse primer  
5′- 7707GCTGACTGTCATAGGATATAATAACGC 7681-3′; and for cDNA clone G4, 
forward primer 5′ -7852CAGCACACCTTGCGAGGGGTA7872-3′ and reverse primer 
5′- 7851CCTATAGAAGATTAGGGGATATGG 7828-3′. Bold, italicized alphabets 
represent the mutated nucleotides, that changed the corresponding amino acid. To 
eliminate each glycosylation site, the asparagine residue in the NXT/NXS sequence motif 
was changed to glutamine. A double HN mutant, G12, was also created by eliminating 
glycosylation sites 1 and 2. This was done by mutating the second glycosylation site on 
the cDNA clone, G1, using the primer specific for making the G2 cDNA clone. All 
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mutant HN cDNAs were sequenced to their entirety to confirm the presence of the 
intentional mutations. The mutagenized Age I- Mlu I fragments were then excised from 
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and 481, respectively. HN G1 mutant has its glycosylation site G1 at residue 119 
eliminated, mutant HN G2 has its G2 glycosylation site at residue 341eliminated, mutant 
HN G3 has its G3 glycosylation site eliminated, mutant HN G4 has its G4 glycosylation 
site at residue 481 eliminated, and the double mutant HN G12 has two of its 
glycosylation sites at residues 119 and 341eliminated. All glycosylation sites were 
eliminated by mutating the asparagine (Asn) residue at each site to glutamine (Glu), using 



















4.4.3 Generation of recombinant viruses 
Transfection and recovery of recombinant NDV were performed as previously 
described (69). Briefly, HEp2 cell monolayers were infected at a multiplicity of infection 
(MOI) of 3 with recombinant vaccinia virus strain MVA/T7 expressing the T7 
polymerase. HEp2 cells were used for transfection since they are permissive for NDV 
growth and resistant to cytopathic effects (CPE) caused by vaccinia virus MVA strain. 
Cells were grown to 80% confluency in 6-well plates, and washed twice with optiMEM 
(Invitrogen) just before transfection. The cells were transfected with 5µg of each of the 
five glycosylation mutant full-length cDNA clones (i.e., G1, G2, G3, G4 and G12) 
together with 2.5 µg NP, 1.5 µg P and 1.0 µg L support plasmids. These were added in a 
volume of 0.2 ml of optiMEM/well. Transfection was done with LipofectamineTM 
Reagent (Invitrogen), according to the manufacturer’s instructions. Cells were incubated 
at 37oC for 8h. The supernatant mixture was then removed and replaced with 3 ml of 
DMEM. Cells were maintained at 37oC for 3-4 days and passaged again in HEp2 cells to 
remove the residual vaccinia virus. The supernatants from the second HEp2 passage were 
used to infect DF1 cells and, after 2-3 days, the cells were examined for typical CPE 
produced by NDV in the form of syncytia. Infectious virus was thus obtained entirely 
from cloned cDNA. Each recombinant virus was plaque-purified on DF1 cells and was 
used to generate virus stocks by growth in 9-11-day-old chicken embryonated eggs. 
Recovered viruses were designated rBC for the virus obtained from transfection with 
wild-type plasmid construct pNDVfl, and rG1, rG2, rG3, rG4 and rG12 for the respective 
mutant viruses obtained from plasmid constructs G1, G2, G3, G4 and G12, respectively. 
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4.4.4 RT-PCR and sequence analysis of the HN gene 
 RNA was isolated from the recovered HN mutant viruses by using TRIzol 
reagent (Invitrogen). RT-PCR was performed using the  Thermoscript RT-PCR kit 
(Invitrogen) with primers  
P1 (5′- 6202GTGAACACAGATGAGGAACG 6221-3′ positive sense ) and P1R  
(5′- 9369ATATCATTGGGGAGGAGGCCG 9349-3′ negative sense) to amplify the HN 
gene. The amplified cDNA fragments were then sequenced using the Themosequenase 
kit (Amersham) to confirm the presence of the introduced mutations in the recovered 
viruses. Primer used to confirm the mutation at G1 (amino acid residue at position119 on 
the HN gene) was: 5′- 6623CATCTGCACTTGGTTCCAATC 6643-3’ for mutation at G2 
(residue 341): 5’- 7294 TGGGTGGCCAACTACCCAGG 7313- 3’ for mutation at G3 
(residue 433): 5’- 7660GGGTCATCATACTTCTCTCCCGCG 7683-3’ for mutation at G4 
(residue 481): 5’- 7660GGGTCATCATACTTCTCTCCCGCG 7683-3′ for mutation at G12 
(residues119 and 341): 5′- 6623CATCTGCACTTGGTTCCAATC 6643-3′ and  
5′ -7294TGGGTGGCCAACTACCCAGG 7313-3′. The HN cDNA amplified by RT-PCR of 
the recovered viruses were also sequenced entirely to ensure that the rest of the sequence 
of the protein remained unchanged.  
 
4.4.5 Characterization of the mutant viruses 
The growth rate of each recombinant virus was examined by multiple-cycle 
growth conditions. The DF1 cells were infected with each virus at an MOI of 0.01. A 
sample of the supernatant was harvested at 8h intervals for a period of 64h. The amount 
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of virus in the supernatant was determined by plaque assay on DF1 cells. Size and 
morphology of the observed plaques were also examined.  
 
The receptor recognition properties of the recombinant viruses were evaluated by 
their ability to adsorb guinea pig red blood cells (RBCs) (65). Confluent monolayers of 
DF1 cells were infected with each virus at an MOI of 10. After 24h at 37oC, the medium 
was removed and the infected cell monolayer was overlaid with guinea pig RBCs in PBS 
at a concentration of 1 × 108 cells/ml. The cells were incubated for 15 min at 4oC. The 
unbound RBCs were washed two times with PBS. The RBCs bound to the virus-infected 
cells were lysed with 0.05 M ammonium chloride. The released hemoglobin 
(hemadsorption activity of the virus) was measured at 549 nm in a spectrophotometer. 
 
The neuraminidase (NA) activity of the recombinant viruses was determined by a 
fluorescence-based NA assay according to the procedures of Potier et al. (110). Briefly, 
serial two-fold dilutions of virus samples were prepared in 50 µl volumes of enzyme 
buffer (32.5 ml of 0.1 2-N-Morpholinoethanesulfonic acid [MES], pH 6.5 and 4.0 ml of 
0.1M calcium chloride made up to a final volume of 100 ml with Milli-Q water) in a 96-
well plate. Ten µl of 12.5% v/v dimethyl sulfoxide (DMSO) was added to all wells of an 
assay plate (black 96-well Microfluor plates, Franklin, MA). Ten µl of each virus dilution 
was transferred in duplicate (2 rows) to the assay plate, starting with the most dilute in 
column 11. Ten µl of enzyme buffer alone was added to each well of column 12 (blank 
wells). The reaction was initiated by the addition of 30 µl per well of substrate mix (1 
volume of 325 mM MES, pH 6.4, 3 volumes of 10 mM calcium chloride and 2 volumes 
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of 0.5mM 2’-(4-methylumbelliferyl)- α-D-N-acetylneuraminic acid [MUN] (Sigma) to 
give a final concentration in the assay of 100 µM MUN. The reaction was incubated at 
37oC for 15 min with shaking, and terminated by the addition of 150 µl per well of 0.014 
M sodium hydroxide in 83% (v/v) ethanol. NA activity of the recovered viruses was 
measured with the 4-methylumbelliferone released from the fluoregenic substrate, MUN. 
Released 4-methylumbelliferone was quantified by fluorometric determination with an 
excitation wavelength of 360 nm and emission wavelength of 450 nm. Readings from the 
substrate blanks were subtracted from the virus sample readings, and the mean values of 
duplicate readings calculated. 
 
The ability of each recombinant virus to form syncytium was determined 
according to the procedures described by Kohn (65). Briefly, confluent monolayers of 
Vero cells were infected at an MOI of 0.1. After 48h at 37oC, the medium was removed, 
and cells were washed once with 0.02% EDTA and incubated with 1 ml of 0.02% EDTA 
for 2 min at room temperature. The cells were then washed with PBS and fixed with 
methanol for 20 min at room temperature. Staining of the cells was done with 1% 
hematoxylin-eosin stain, using the Hema 3 Stain Set (Biochemical Sciences, Inc., NJ). 
The syncytia were quantitated by determining the fusion index for each virus. Fusion 
index is the ratio of the total number of nuclei to the number of cells in which these 





4.4.6 Radioimmunoprecipitation and analysis of stability of HN protein 
DF1 cells were infected with recombinant viruses at an MOI of 10. After 4h 
incubation at 37oC, the medium was removed, and the cells were washed with PBS and 
starved in 5 ml of methionine-cysteine-free medium (Invitrogen) for 30min. The cells 
were then pulse-labeled for 2h, with medium containing 100 µCi of 35 [S] methionine-
cysteine (1000 Ci/mmol; Amersham, Arlington Heights, IL) per mL. After labeling, cells 
were washed in PBS and lysed in cold radioimmunoprecipitation (RIPA) buffer {20mM 
Tris (pH 7.5), 150 mM NaCl, 5 mM EDTA (pH 8.0), 0.5% sodium deoxycholate, 0.1% 
sodium dodecyl sulfate (SDS), 1.0% Triton X-100}. The cell lysates were centrifuged to 
remove the nuclei. Immunoprecipitations were performed by adding anti-NDV-specific 
polyclonal antibody to the cell lysates and incubating for 3h at 4oC. Immune complexes 
were precipitated by incubating with Staphylococcus aureus protein A for 30min. 
Immune complexes were then solubilized by boiling in buffer H (1% SDS, 0.15 M Tris 
HCl, pH 7.5). Solubilized proteins were analyzed on 12% SDS polyacrylamide gels 
(SDS-PAGE). A portion of each solubilized protein was digested with endoglycosidase H 
(Endo H) (Boehringer-Mannhiem Corp). Briefly, Endo H (1.5 mU) and sodium citrate 
buffer (0.05 M, final concentration), pH 5.5, were added to the immunoprecipitated 
proteins and incubated overnight at 37oC. The digestion was stopped by boiling and the 
samples were analyzed on 10% SDS-PAGE. 
  
To assess the stability of the HN proteins of the recombinant viruses, equal 
amounts of each purified virus sample were analyzed on 10% SDS-PAGE gel. The 
concentration of the viral proteins of each recombinant virus was standardized using the 
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Micro BSATM protein assay reagent kit (Pierce, IL). A premixed protein molecular 
weight marker (Low range 14.4-97.4 kD) (Boehringer Mannheim Corp) was also run on 
the gel, to distinguish the viral proteins based on their molecular weights. The HN protein 
of NDV has an approximate molecular weight of 74 kD.The gel was stained with 
Commassie blue to visualize the viral proteins. Stability of the HN protein of the 
recombinant viruses was also assessed by radioimmunoprecipitation studies. 
Immunoprecipitated complexes described earlier were stored at 4oC and run in SDS-
PAGE gels on days 1, 3, 5 and 7 post-immunoprecipitation. The HN protein in the 
radiographs was captured using the Kodak ID TM Camera and the amount of protein was 
determined with the Fuji Image Gauge 3.46 software. 
 
4.4.7 Cell surface expression of HN proteins  
DF1 cells were grown to 70% confluence in 6-well plates. Virus was inoculated at 
an MOI of 0.1 and the cells were maintained in DMEM medium with 5% fetal bovine 
serum at 37oC. After 48h, the cells were washed with PBS and fixed onto the plate with 
3% paraformaldehyde in PBS for 30 min. After washing 3 times with PBS, the cells were 
permeabilized with 0.1% Triton X-100 in PBS for 30min. Following three further washes 
with PBS, the cells were treated with 1:500 dilution of primary antibody (HN-specific 
monoclonal antibody) in PBS at room temperature for 30min. The cells were then rinsed 
with PBS and incubated with affinity-purified, fluorescein-labeled goat anti-mouse 
immunoglobulin (Kirkegaard and Perry Laboratories), for 30 min. The cells were washed 
once again with PBS and visualized under a Nikon Eclipse TE 300 (Nikon, Japan) 
fluorescent microscope.  
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4.4.8 Flow cytometry 
  DF1 cells were infected with each virus at an MOI of 1. After 16h, the cells were 
washed once with calcium-and magnesium-free PBS containing 0.02% sodium azide 
(PBSA). The cells were lifted off the dish with PBS containing 50 mM EDTA. The cell 
suspensions were washed once with PBSA and then bound with a mixture of a cocktail of 
NDV HN-specific monoclonal antibodies (72) at a dilution of 1:200, and incubated on ice 
for 30min. The cells were washed three times with PBSA and bound with a fluorescein 
isothiocyanate-conjugated goat anti-mouse immunoglobulin (Kirkegaard and Perry 
Laboratories), for 30min on ice. Cells were then washed three times with PBSA. The 
fluorescence of 10,000 cells was measured with a FACS Vantage flow cytometer (Becton 
Dickinson).  
 
4.4.9 Enzyme Linked Immunosorbent Assay  (ELISA) 
The reactivity of the HN-specific monoclonal antibodies (MAbs) of NDV was 
tested in a standard ELISA test. The MAbs used were 15C4, AVS, B79, and 10D11 (72). 
The MAb 15C4 neutralizes and inhibits hemagglutination (HA) of all lentogenic, 
mesogenic, and velogenic NDV strains, but not the pigeon paramyxovirus-1 (PPMV-1) 
strain. Antibody 10D11 also inhibits HA activity, but inhibition is more selective and is 
limited to the mesogenic and domestic, or indigenous, velogenic strains of NDV. MAb 
B79 reacts in all serologic assays with an antigenic site common to all serotype 1 avian 
paramyxoviruses. AVS is paramyxovirus-1 (PMV-1) lentogenic strain specific MAb, 
which reacts with avirulent strains only. The MAb 8, which does not react with any of the 
NDV strains but only with infectious bursal disease virus, was used as a negative control. 
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Equal amounts of purified parental and mutant recombinant viruses were used as 
antigens. The concentration of the viral proteins of each recombinant virus was 
standardized using the Micro BSATM protein assay reagent kit (Pierce). A 1:2000 dilution 
of MAbs was used in the ELISA test. Affinity-purified peroxidase-labeled goat anti-
mouse immunoglobulin (Kirkegaard and Perry Laboratories) was used as the secondary 
antibody. The results of the ELISA were graded as + to ++++, depending on the 
reactivity of MAbs to the virus. Uninfected cell antigen was used as a negative control. 
 
4.4.10 Pathogenicity studies 
 The virulence of the recombinant viruses was determined by three in vivo tests: 
the mean death time (MDT), intracerebral pathogenicity index (ICPI) and intravenous 
pathogenicity index (IVPI) tests.  
 
MDT was determined to examine the pathogenicity of the recombinant viruses in 
embryonated chicken eggs as described previously (1). Briefly, a series of 10-fold 
dilutions of fresh, infective allantoic fluid were made in sterile PBS, and 0.1 ml of each 
dilution was inoculated into the allantoic cavity of each of five 9-day-old embryonated 
chicken eggs. The eggs were incubated at 37oC and examined four times daily for 7 days. 
The time that each embryo was first observed dead was recorded. The highest dilution 
that killed all embryos was considered the minimum lethal dose. The MDT was recorded 
as the mean death time in hours for the minimum lethal dose to kill the embryos. The 
MDT has been used to classify NDV strains into velogenic (taking under 60h to kill); 
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mesogenic (taking between 60h to 90h to kill) and lentogenic (taking more than 90h to 
kill).  
To examine the pathogenicity of recombinant viruses in vivo in chickens, the ICPI 
and IVPI tests were performed as described elsewhere, with modifications (1). For ICPI,  
103 PFU of each virus/bird was inoculated into groups of 10 one-day-old SPF chicks, via 
the intracerebral route. The inoculation was done using a 27-guage needle attached to a 
1ml stepper syringe dispenser that was set to dispense 0.05 ml of inoculum per 
inoculation. The birds were inoculated by inserting the needle up to the hub into the right 
or left rear quadrant of the cranium. For IVPI, 103 PFU of each virus/bird was inoculated 
intravenously into groups of 10 six-week-old chickens. The dispenser was set to dispense 
0.1 ml of inoculum per inoculation. In both studies, the birds were observed for clinical 
symptoms and mortality every 12 h for a period of 8 days for ICPI, and 10 days for IVPI 
studies, respectively. Each experiment had mock-inoculated controls that received a 
similar volume of sterile PBS by the respective routes. The ICPI and IVPI values were 












4.5.1 Generation of recombinant NDV containing the HN N-linked 
glycosylation site mutations 
  Previously, recovery of recombinant NDV from an infectious cDNA clone 
(pNDVfl) derived from a mesogenic strain of NDV, BC, has been reported from our 
laboratory (69). In this study, the established reverse genetics system was used to 
determine the role of N-linked carbohydrates of the HN protein on the biological 
activities of NDV. To achieve this goal, the AgeI-MluI subclone containing the HN gene 
derived from the full-length clone of BC (pNDVfl) was mutated. Each of the four 
functional N-linked glycosylation sites (81) were altered by site-directed mutagenesis 
changing asparagine, the first amino acid residue of the acceptor site, to glutamine (Fig. 
12). Substitutions were made by altering the first and third positions (bold and 
underlined) of each asparagine codon to create a codon for glutamine (AAT or AAC to 
CAG). Glutamine was chosen because it is structurally similar to asparagine, differing by 
only a single methylene group. Moreover, a minimum of two nucleotide changes are 
necessary for the altered sequence to revert to any codon specifying asparagine, thereby 
reducing the likelihood of direct reversion of the targeted codon during virus replication 
in vivo. To examine the effect of the combined loss of two N-linked glycosylation sites, a 
double mutant was also created by eliminating the N-linked glycosylation sites 1 and 2 
(G1 and G2, respectively). The mutant HN cDNA subclones were then inserted into the 
full-length cDNA of BC (pNDVfl), thus generating four single mutant (G1, G2, G3 and 
G4) and one double mutant (G12) cDNA clones. To ensure the presence of the 
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introduced mutations, the entire HN cDNA clone was sequenced using dideoxy chain 
termination method.   
 
Recombinant viruses expressing wild-type HN, rBC; expressing mutant protein 
G1, rG1; expressing mutant protein G2, rG2; expressing mutant protein G3, rG3; 
expressing mutant protein G4, rG4; and expressing mutant protein G12, rG12 were 
recovered by transfection of  HEp2 cells with full-length mutant HN cDNA clones and 
support plasmids, and amplification of viruses in DF1 cells.  Recovered viruses were 
subjected to RT-PCR and the HN genes were sequenced to their entirety to confirm the 
presence of the introduced mutations. To determine the stability of each HN mutation, the 
recovered viruses were passaged five times in 9-11-day-old embryonated chicken eggs 
and the sequence of the HN gene was determined in viruses recovered at each passage 
level. These sequence analyses showed that the introduced HN mutations were unaltered, 
even after five egg passages (data not shown).  
 
4.5.2 Growth and plaque morphology of mutant viruses 
The efficiency of replication of the parental (rBC) and mutant (rG1, rG2, rG3, 
rG4 and rG12) viruses were compared in a multi-step growth cycle. DF1 cells were 
infected in triplicate with each virus at an MOI of 0.01, and samples were collected at 8h 
intervals for quantitation by plaque assay on DF1 cells (Fig. 13). The replication kinetics 
of the mutant viruses were comparable to that of the parental virus. Interestingly, rG4 and 
rG12 viruses showed delayed growth kinetics (1.5 to 2.0 log units lower) compared to the 
parental and other mutant viruses. However, after 40h, the virus titer of rG4 reached a 
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level comparable to that of the parental virus, but rG12 was 1.0 log unit lower than that of 
the parental virus. From 48h onwards, the differences in viral growth were insignificant 
between the parental and mutant viruses. The onset of cell fusion was also delayed for 
rG4 and rG12 viruses. The rG4 virus took 48h while the rG12 virus took 24h longer than 
the parental virus to produce syncytium in DF1 cells. Most mutant viruses had similar 
plaque sizes as the parental virus, measuring 3-5 mm in diameter, except the mutants rG4 
and rG12, which had considerably smaller-sized plaques (1-2 mm in diameter), as shown 


















































Figure 13. Growth kinetics of viruses in tissue culture. Multicycle growth of parental and 
HN glycosylation mutant viruses in chicken embryo fibroblast (DF1) cells.  Cells were 
infected at an MOI of 0.01 with the indicated parental or chimeric virus. Samples were 
taken at 8h intervals and virus titers were determined by plaque assay.  Values are 
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Figure 14.  Plaque morphology in DF1 cells by wild-type and HN glycosylation mutant 
viruses 4 days post-infection. Recovered viruses were titrated in duplicates in 12-well 
plates. Supernatant collected from virus-inoculated samples was serially diluted and 
100µl of each serial dilution was added per well to confluent DF1 cells. After 60min of 
adsorption, cells were overlaid with DMEM (containing 2% fetal bovine serum and 0.9% 
methyl cellulose) and incubated at 37oC for 3-4 days. The cells were then fixed with 
ethanol and stained with crystal violet for observation of plaques. Plaque size and 




4.5.3 Analysis of the HN protein of glycosylation mutants by 
radioimmunoprecipitation assay  
  To confirm that the mutated glycosylation sites actually lead to the loss of 
carbohydrates in the HN protein, DF1 cells infected with recombinant NDVs expressing 
the mutant HN proteins were labeled with 35[S] methionine-cysteine 4-6h after infection. 
The labeled proteins were immunoprecipitated from cell lysates with NDV-specific 
polyclonal antibodies and analyzed by SDS-PAGE (Fig. 15 A). One half of the cell 
lysates were treated with endoglycosidase H (Endo +) and the other half was undigested  
(Endo H -). Both the samples were subjected to SDS-PAGE analysis (Fig. 15B). Our 
results showed that Endo H-digested mutant HN proteins (Endo H +) comigrated with the  
parental viruses on polyacrylamide gels. In the undigested samples, the HN proteins of 
single mutants (G1, G2, G3 and G4) migrated slightly faster on polyacrylamide gels than 
the parental HN protein, while the HN protein with mutations in two sites (G12) migrated 
faster than the single-mutant HN proteins. Protein missing site 1 migrated slower than 
protein missing sites 2, 3, or 4. These results corroborated with earlier findings with 
transfected mutant plasmids  (81) that glycosylation sites at residues 119, 341, 433 and 
481 are actually used in the HN protein of NDV. Further, the slightly slower migration of 
the G1 mutant than the other mutants, reported earlier and also in our study, may be due 
to a smaller carbohydrate linked to site 1 than those linked to other sites (81). Variation in 
size of carbohydrate side chains has been observed in other glycoproteins (97, 130). This 
study confirmed the usage of glycosylation sites 1-4 on the HN protein of the viruses. 
None of the precipitated proteins, Endo H-digested or undigested, including the parental 
HN protein, showed any partially-resistant side-chains reported earlier (81) in 
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polyacrylamide gels. There were no partially Endo H-resistant species after Endo-H 
digestion of metabolically-labeled NDV HN protein. However, the amount of 
precipitated protein with rG4 mutant virus was extremely small (Figs.15A, B and C). 
Commassie blue staining of purified virus run in 10% SDS-polyacrylamide gels also 
showed extremely small amounts of HN protein of rG4 virus (Fig. 16). This suggests that 
mutation of the glycosylation site 4 (Asn-481) inhibited the maturation of HN 
glycoprotein of NDV. This was further seen in immunoprecipitation experiments (Fig. 
15C) in which the immunoprecipitated cell lysates were stored at 4oC and analyzed on 
polyacrylamide gels on days 1, 3, 5 and 7 after immunoprecipitation. It was found from 
HN protein quantitation results (data not shown) that there was gradual degradation of the 
HN proteins of all mutants with increasing time points. Thus, the involvement of some 
other mechanism other than instability of the protein may be the reason for production of 
relatively lesser amounts of HN protein in cells infected with glycosylation mutant rG4. 
Pulse-chase experiments also indicated that the small amounts of rG4 HN protein 
precipitated were not due to the instability of the protein, since all proteins were 
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Figure 15C. Analysis of stability of the HN protein of glycosylation mutants and parental 
virus with radioimmunoprecipitation assay. DF1 cells infected with each of the viruses 
for 4-6h and proteins were labeled with  [35S] methionine-cysteine for 2h. Equal amounts 
of cell lysates were immunoprecipitated with a cocktail of NDV-specific polyclonal 
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antibodies and Staphylococcus aureus protein A. Immunoprecipitates were stored at 4oC 
and stability of the NDV HN protein was assessed by running each sample in SDS-PAGE 
gels on days 1, 3, 5 and 7 after immunoprecipitation. Cells infected with the virus rG4 
were maintained at 37oC and 39oC to check whether this mutant was temperature-
sensitive. The HN proteins of all mutants showed gradual degradation with time. The 
amount of rG4 HN protein immunoprecipitated was lesser when compared to the HN 
protein precipitated from other mutants. 
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Figure 16.  Expression of HN protein glycosylation mutants. Equal amounts of proteins 
from parental and mutant purified viruses were analyzed by SDS-PAGE. The migration 
and protein stability of the HN protein from each virus was examined after Commassie 
blue staining. The HN protein of mutant rG4 virus was found to be degraded. A protein 
molecular weight marker was also run along with the purified viral samples to assess the 
viral proteins based on their molecular weights. The molecular weight of the HN protein 
of NDV is approximately 74kD. Three independent experiments with purified viral 
proteins confirmed the degradation of the HN glycoproteins of the rG4 mutant virus.  
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4.5.4 Reactivity of glycosylation mutant HN proteins with monoclonal 
antibodies   
It is suggested that formation of antigenic sites present only on mature HN 
molecule is a measure of maturation of the protein (81). In order to examine the effect of 
loss of carbohydrate on the formation of antigenic sites, the parental and mutant viruses 
were tested for reactivities to a panel of HN-specific monoclonal antibodies (15C4,  
10D11, B79 and AVS) by ELISA. Purified parental and mutant viruses were used as 
antigens. ELISA results showed that all mutant proteins reacted with most of the 
antibodies tested except the mutants rG2 and rG4. None of the mutants and the parental 
virus reacted to MAb AVS, which recognizes only avirulent strains, and MAb 8, which 
recognizes a totally unrelated virus, as expected. The mutant rG1, rG3 and rG12 viruses  
showed higher rates of reactivity than the other mutants with MAb B79, and rG1 and rG3 
viruses showed higher reactivity to MAb 15C4, compared to the parental rBC and other 
mutant viruses. The rG4 and rG2 viruses were poorly reactive to the 15C4 and B79 
Mabs, but were totally unreactive to the MAb 10D11. Table 2 shows the reactivity of 
HN-specific MAbs to parental and mutant viruses. Thus, loss of different carbohydrate 
side chains differentially influences the formation of antigenic epitopes. The presence of 
the G2 and G4 mutations eliminated the detection of a particular epitope recognized by 
the 10D11 MAb. The varying efficiency of binding to 15C4 and B79 antibodies by rG4 
and rG2 viruses suggests that a significant population of these mutant proteins remain at 




Table 2. Monoclonal antibody (MAb) reactivity, Endo H sensitivity and cell surface 
expression of HN glycosylation mutant viruses.   
 
 
           Monoclonal antibody reactivity         Endo H sensitivity†   Cell surface expression‡ 
 




rBC      + + +         +          +         -         -                     S                           Yes 
 
rG1      + + + +      +       + + +      -         -                     S                           Yes 
 
rG2        + +           -           -          -         -                     S                           Yes 
 
rG3      + + + +      +       + + +       -        -                     S                            Yes 
 
rG4        + +           -           +          -        -                     S                            Yes              
 
rG12    + + +         +       + + +        -        -                     S                           Yes 
 
 
The reactivity of the HN specific MAbs to the HN protein of NDV was tested by an 
ELISA. Equal amounts of proteins from parental and mutant purified viruses were used 
as coating antigens. The MAbs were diluted 1:2000 of MAbs in dilution buffer. Affinity-
purified, peroxidase-labeled goat anti-mouse immunoglobulin (KPL, Gaithersburg, MD) 
was used as the secondary antibody. The data are presented as the relative amount of HN 
captured by each of the MAbs: ++++, absorbance 450 > 2.0; +++, absorbance 450 > 1.1; 
++, absorbance 450 0.9-1.0; + absorbance 450 0.5-0.8; and -, absorbance 450 < 0.4. Data are 
from three independent experiments. † Abbreviations: S, Carbohydrate side chains were 
sensitive to Endo H digestion. Data are from three independent experiments.  ‡ Cell 
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surface expression was analyzed by indirect immunofluorescence with anti-HN MAb 























4.5.5 Cell surface expression of glycosylation mutant HN proteins 
To study the transport of the mutant HN proteins synthesized in virus-infected cells from 
the cytoplasm to the cell surface, indirect immunofluorescence studies were carried out. 
The infected cells were fixed with 3% paraformaldehyde, washed and then permeabilized 
with 0.1% Triton X-100. The cells were viewed under a fluorescent microscope after 
being treated with NDV HN-specific monoclonal antibody followed by incubation with 
affinity-purified fluorescein-labeled goat anti-mouse immunoglobulin. As shown in 
Fig.17, all mutant and the parental viruses showed the presence of surface 
immunofluorescence in fixed cells, and internal cytoplasmic immunofluorescence in 
fixed and permeabilized cells.  Flow cytometry was used to quantitate these results. DF1 
cells infected with each of these viruses were incubated with HN-specific MAb cocktail,  
and surface expression was determined by flow cytometry. The percentage of cells 
expressing the different mutated HN proteins was very similar except for rG4 virus, 
which had a slightly lower percentage (76%) of cells expressing the HN at the surface 
(Table 3). The mean fluorescence intensities ranged from 60 to 220 % of the parental rBC 
virus. Cells infected with the rG4 virus had a reduced percentage of mean fluorescence 
intensity than that of the parental rBC virus. The surface expression of the HN proteins of 
rG1, rG2 and rG3 viruses was higher than that of the rBC virus. These results indicated 
that all glycosylation mutant HN proteins retained the ability to be transported to the cell 
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Figure 17.  Detection of cell surface immunofluorescence of parental and mutant HN 
proteins. Virus-infected DF1 cells (0.1 MOI) were washed with PBS at 48h post-infection 
and fixed with 3% paraformaldehyde in PBS for cell surface fluorescence (b, d, f, h, j, l 
and n), or fixed and then permeabilized with 0.1% Triton X-100 in PBS for 
intracytoplasmic fluorescence (a, c, e, g, i, k and m). HN proteins were stained with anti-
HN monoclonal antibody cocktail, followed by affinity-purified fluorescein-labeled goat 
anti-mouse immunoglobulin (KPL, Gaithersburg, MD). (a,b) rBC; (c, d) rG1; (e, f) rG2; 
(g, h) rG3; (i, j) rG4; (k, l) rG12 and (m,n) negative control. Cells were photographed at a 
magnification of 200X.  
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Table 3. Surface expression of HN proteins of glycosylation mutants.  
 
                                                             Surface expression efficiency of HN protein 
 
     Virus                                          % of positive              Relative mean fluorescence  
                                                             cells                                     intensity 
 
 
       rBC                                                  87                                          1.00 
 
       rG1                                                  90                                           1.60 
 
       rG2                                                  96                                           2.20 
 
       rG3                                                  97                                           2.00 
 
       rG4                                                  76                                           0.60 
 
       rG12                                                88                                           1.00 
 
Mock-infected cells                                -                                             0.01                                    
 
Cell surface expression of HN was determined by flow cytometry. DF1 cells were 
infected at an MOI of 1 with each virus. Surface expression of the HN proteins was 
assessed by flow cytometry at 18h post-infection with a cocktail of NDV HN-specific 
monoclonal antibodies followed by a fluorescein-isothiocyanate secondary antibody. 
Surface immunoflurescence was quantitated by FACS analysis using the FACS Vantage 
flow cytometer (Becton Dickinson, CA, USA). Uninfected DF1 cells were used as 






4.5.6 Biological activities of glycosylation mutant viruses. 
The results described above show that glycosylation at sites 2 and 4 affects the formation 
of a mature HN molecule. But, the cell surface expression of virus missing site 2 was 
similar to the parental virus. However, proteins missing oligosaccharides at sites 1, 3 
singly or sites 1 and 2 in combination have no effect on antigenic site formation or cell 
surface expression.  To explore the role of these carbohydrates in the biological activities 
of the HN protein, cells infected with the recombinant viruses were assayed for NA, HAd 
and fusion activities (Fig. 18A). Our results showed that the NA and HAd values of all 
glycosylation mutant viruses were similar to that of parental virus, indicating that 
glycosylation probably does not play a role in NA and HAd activities of NDV. However, 
differences were observed in fusion promotion activity of the HN protein. The fusion 
indices of rG1, rG2 and rG3 viruses were similar to that of the parental virus, rBC. 
Surprisingly, the rG12 virus showed more than 1.8-fold higher fusogenicity, and the 
fusion promotion activity of rG4 virus was approximately one-third of the parental virus. 
The rG4 virus also showed reduced surface expression. The extents of fusion of parental 




































Figure 18A. Biological activities of the HN glycosylation mutants. The hemadsorption 
(HAd), neuraminidase (NA) and fusogenicity of HN glycosylation mutants were 
examined. HAd was measured as the percentage of the hemoglobin released compared to 
the parental rBC virus. The NA activities and fusion indices (FI) of the mutant viruses 
were also shown in comparison with these activities of the rBC virus. NA activity of 
purified viruses was measured by a fluorometric assay. The FI is the ratio of the total 
number of nuclei to the number of cells in which the nuclei were observed (i.e., the mean 
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Figure 18B. Fusion of HN glycosylation mutants.The fusogenicity of the mutant viruses 
in Vero cells in comparison to the parental rBC virus. Infected cells were fixed at 48h 
post-infection and stained with hematoxylin-eosin. The extent of fusion of the parental 
rBC (a) and the mutant viruses rG1, rG2, rG3, rG4 and rG12 (b, c, d, e and f) in Vero 
cells are captured at 200X magnification in a Nikon Eclipse TE 300 microscope. 
Uninfected Vero cell monolayer (g) is included as a negative control for comparison. 
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4.5.7 The effect of loss of glycosylation from the HN protein on virulence 
Three internationally-accepted tests were used to assess the degree of virulence of NDV 
isolates: the MDT test in 9-11-day-old embryonated SPF chicken eggs; the ICPI test in 1-
day-old chicks, and the IVPI test in 6-week-old chickens. We examined the virulence of 
the parental and glycosylation mutant viruses by all three tests (Table 4). The MDT result 
showed a significant increase in the time required by rG4 virus (70h) to kill the chicken 
embryos when compared to the time required by the parental rBC virus (62 h), indicating 
a reduction in virulence of rG4 in vivo.  The rG1 and rG3 viruses had MDT values of 60h 
each; whereas, rG2 and rG12 had MDT values of 64h each. The ICPI values of all 
glycosylation mutants were lower compared to the parental virus (Table 3). The ICPI 
value of parental rBC virus was 1.50; whereas, the ICPI values of rG1, rG2, rG3, rG4 and 
rG12 viruses were 1.12, 0.87, 1.07, 0.66 and 0.76, respectively. The results obtained by 
IVPI tests in 6-week-old chickens showed that all glycosylation mutants had lower IVPI 
values compared to that of the parental virus. There was a discrepancy between the ICPI 
and IVPI values for rG1 and rG2 viruses. These viruses showed higher ICPI values when 
compared to the rG12 virus. However, they showed lower IVPI values when compared to 
the IVPI value of the rG12 virus. The IVPI value of parental rBC virus was 1.32; 
whereas, the IVPI values of rG1, rG2, rG3, rG4 and rG12 viruses were 0.37,  
0.44, 0.75, 0.31 and 0.67, respectively. These results indicated that loss of glycosylation 
in the HN protein leads to reduction in virulence of NDV. They further indicated that loss 
of glycosylation at residue 481 (G4) or at residues 119 and 341 (G12) significantly 
reduced the virulence of NDV.  
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          Virus                        MDTa                          ICPIb                             IVPIc 
 
 
            rBC                            62                              1.50                             1.32 
            rG1                            60                               1.12                             0.37 
            rG2                            64                               0.87                             0.44 
            rG3                            60                               1.07                             0.75 
           rG4                             70                               0.66                             0.31 
           rG12                           64                               0.76                             0.67 
 
 
The virulence of the mutant and parental viruses was evaluated by intracerebral 
pathogenicity index (ICPI) in day-old-chicks, intravenous pathogenicity index (IVPI) in 
six-week-old chickens, and mean death time (MDT) in eggs. a MDT in hours for the 
minimum lethal dose to kill 9-day-old embryonated chicken eggs by allantoic route of 
inoculation.  
Highly-virulent viruses take under 60h to kill the embryos, whereas, avirulent viruses 
take more than 90h to kill the embryos. b ICPI was determined by inoculating 103 PFU of 
each virus/bird, into groups of 10 one-day-old SPF chicks, via the intracerebral route. The 
inoculation was done using a 27-guage needle, attached to a 1ml stepper syringe 
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dispenser that was set to dispense 0.05 ml of inoculum per inoculation. The birds were 
observed daily for 8 days and at each observation, scored 0 if normal, 1 if sick, and 2 if 
dead. The ICPI value is the mean score per bird, per observation. Highly-virulent viruses 
give values approaching 2 and avirulent viruses give values approaching 0. c IVPI was 
determined by inoculating 103 PFU of each virus/ bird, intravenously, into groups of 10 
six-week old chickens. The dispenser was set to dispense 0.1 ml of inoculum per 
inoculation. The birds were observed daily for a period of 10 days for clinical symptoms 
and mortality. They were scored 0 if normal, 1 if sick, 2 if paralyzed and 3 if dead. The 
weighted sums were then added and divided by the total number of observations (10 birds 
x 10 days = 100 observations), which provided the mean score per bird, per observation.  
Both ICPI and IVPI studies had mock-inoculated controls that received a similar volume 
















Carbohydrates play important roles for a variety of structural and functional activities 
of glycoproteins (100, 101, 112,114,123,143). Previous studies have shown that N-linked 
carbohydrates are important for folding, transport and biological activities of the HN 
glycoprotein of NDV (30, 60, 81). We have characterized N-linked glycosylation mutants 
of NDV HN protein in terms of their biological activities and virulence. By using reverse 
genetics, we analyzed the role of individual N-linked oligosaccharides on the 
pathogenicity of NDV in its natural avian host.  
 
It has been reported that only four of the six putative N-linked glycosylation sites 
in the NDV HN sequence are normally used for carbohydrate addition (81). Our results 
confirmed this finding. Further, we have shown that all four glycosylation sites in the HN 
glycoprotein could be mutated individually without adversely affecting the recovery of 
replication-competent NDV. A double HN glycoprotein mutant virus lacking 
carbohydrates in sites 1 and 2 was also recovered. Similar to other virus systems (61, 
115), conserved N-linked oligosaccharides of NDV HN protein are dispensable for viral  
replication, and loss of individual glycosylation sites in the HN protein has minimal 
effects on the biological activities of NDV.  
 
The effect of substitution of single, or combinations of several, amino acid 
residues on HN protein expression and function has been reported for NDV (30, 60, 81),  
 96
but none of the studies looked at the role of individual N-glycans in viral replication. We 
recovered viruses with individual mutations at glycosylation sites 1, 2, 3, and 4, and a 
combined mutation at glycosylation sites 1 and 2, and tested the effects of these 
substitutions on viral replication in DF 1 cells. Surprisingly, viruses with mutations at site 
4 (rG4) and sites 1 and 2 (rG12) had decreased growth rates and smaller plaque sizes than 
the other mutants or the parental virus. Each of the individual sites is dispensable for 
virus replication, although all sites appear to contribute optimal replication efficiency. 
Glycosylation sites 1-4 are highly conserved in the HN protein of 13 different strains of 
NDV (119), which suggests that these sites are used and that all four side chains serve 
important biological functions (81). But conserved glycosylation sites in NDV are found 
to be largely dispensable for virus replication. Conserved N-linked glycans of human 
immunodeficiency virus type 1 gp41 envelope protein were found to be dispensable for 
viral replication (61). The differences in replication and the severe defects in replication 
displayed by G4 and G12 mutants may be the result of inefficient processing of the HN 
protein. At least for G4 virus, we demonstrated that the cell surface expression was 
compromised in comparison to the other mutants. 
 
Antibody-selected N-glycan addition to HN protein of NDV decreased the ability 
of HN protein to complement the viral F protein in the promotion of cellular fusion (30). 
In our study, even though the in vitro growth rate of rG12 virus was lower, its 
fusogenicity was significantly higher when compared to the parental virus. Its cell surface 
expression was similar to the parental virus. This result is in agreement with a previous 
study by McGinnes and Morrison (1995), who demonstrated higher fusogenicity of G12 
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double mutant virus when compared to the parental virus. Increased fusion by rG12 may 
be due to the location of the first glycosylation site (residue119) on the HN protein. It is 
located near the Cys-123 residue in the stalk region of the HN protein. This cysteine 
residue plays an important role in the disulfide linkage of the HN homodimers (80, 85, 
109). Elimination of glycosylation at residue 119 may result in better covalent linkage by 
increasing the efficiency of participation of the adjacent cysteines in the covalent bond, as 
indicated by McGinnes and Morrison (81).  Alternatively, it is possible that the 
simultaneous elimination of carbohydrates at residues 119 and 341 may result in better 
interaction of the HN mutant G12 with the F protein, leading to increased fusogenicity of 
rG12 virus. This may result in the formation of a very stable tetrameric HN protein which 
can interact more efficiently with the fusion (F) protein of the virus and, thus, cause 
increased fusion when compared to the parental virus. Interaction of the HN and F 
proteins as requirements for cell fusion has been reported previously (129, 138).  
 
In vivo studies with rG12 virus showed loss of virus virulence in chickens. It is 
possible that removal of these glycosylation sites (residues 119 and 341) increases cell-
cell fusion, resulting in rapid spread and destruction of the host cell monolayers. The 
antigenic reactivity of rG12 virus to the MAb B79 is higher than that of rBC virus. This 
mutant may thus cause an early and enhanced immune response in infected chickens, and 
hence, would be cleared by neutralizing antibodies of the immune system in the chickens 
during the initial stages of infection. This would prevent its spread in the chickens, 
making rG12 virus less virulent in vivo. Thus, the presence of carbohydrates at residues 
119 and 341 may serve to modulate viral infection and increase the survival time of the 
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virus in the host. Our ICPI results corroborate this inference, as chicks inoculated with 
G12 mutant survived longer than the other mutants. There have been reports of an 
increase in virulence of a neurovirulent influenza virus strain A/NWS/33 in mice (146) 
and the H5N2 influenza virus in chickens (63), with the loss of a carbohydrate from the 
HA protein of the viruses. Thus, loss of a glycosylation site(s) can influence the 
pathogenicity of viruses by either decreasing or increasing their virulence.  
 
Carbohydrates masking neutralization epitopes on the viral surface glycoproteins, 
thus forming a shield that protects the virus from immune recognition, has been reported 
for many viruses (3, 4, 28, 58, 127, 135). We have shown that removal of carbohydrate 
side chains resulted in exposure or masking of the antigenic sites in NDV HN protein. 
The reactivity to neutralizing NDV monoclonal antibodies increased when the 
glycosylation at sites 1 (G1), 1 and 2 together (G12), and 3 (G3) were removed. On the 
other hand, loss of glycosylation at sites 2 and 4, lead to reduction of reactivity of rG2 
and rG4 viruses, respectively, to the monoclonal antibodies. Previous studies have 
defined residues 193 to 201, 345 to 353, 494, 513 to 521, and 569 as the domains on the 
HN protein of NDV that are involved in neutralization (56, 58, 59).  
 
The bulky hydrophilic carbohydrate chains in N-glycosylated proteins may aid 
protein folding by preventing inappropriate hydrophobic interactions. The role of 
individual oligosaccharides in the maturation of SV5, measles and sendai viruses has 
been studied. Those studies showed, as did ours, that the loss of some oligosaccharides 
influenced folding more than the loss of others.  In simian virus 5 (SV5), removal of 
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oligosaccharides from the F1 subunit of the F protein of SV5 resulted in delayed 
intracellular transport and decreased stability of the protein (5). In measles and SV5 
viruses, glycosylation has been shown to be necessary for folding of proteins into their 
native conformation, which, in turn, affects the protein stability and intracellular transport 
(52, 97). In Sendai virus, the loss of glycosylation sites 3 and 4 affected the transport of 
the HN protein to the cell surface (128). In our study, glycosylation site 4 of the HN 
protein of NDV is found to be necessary for correct folding, as the misfolded HN protein 
is incorrectly processed and transported to the cell surface inefficiently. Loss of this 
oligosachharide reduces the formation of antigenic sites to approximately one-third the 
level of the parental virus. The cell surface expression of this virus was also only 60% of 
the parental virus. Loss of oligosaccharides at site 2 had some effect on formation of 
antigenic sites, while mutants with deletion of sites 1, 3 and 1and 2 together, had little or 
no effect on the formation of antigenic sites, but had either increased or similar levels of 
cell surface expression as that of the parental virus. The glycosylation site 4 is located in 
the globular head and is likely to contribute to the conformation of the protein. Our 
results are in agreement with those of McGinnes and Morrison (1995), who also observed 
that oligosaccharides at residue 481 had the most significant effect on folding of the HN 
protein of NDV.  Since the HN protein mediates the attachment of the virus to host cells, 
a misfolded HN protein in the mutant virus would result in loss of infectivity and 
virulence of the virus. We have demonstrated that the loss of glycosylation at site 4 
decreases the biological activities of the HN glycoprotein and attenuates the virus 
considerably. It is noteworthy, that we were also able to recover the mutant virus with 
loss of glycosylation at site 4 (rG4), even though the production and cell surface 
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expression of the HN protein in this virus was lower when compared to the other mutants 
and the parental viruses.  
 
A number of studies have shown that N-linked glycans influence proper folding, 
disulfide bond formation, and oligomerization of proteins, and affect the conformation of 
proteins (5, 52, 80, 81, 97). Whether this conformational change affects the ability of the 
N-linked glycosylation mutants to function in NDV virions has not been tested so far. 
Our results provide evidence that N-linked glycans are important for the functional 
integrity of the virions. The loss of an individual glycosylation site in the globular head 
region of NDV or a combined loss of glycosylation sites from stalk and globular head 
region of NDV resulted in attenuating the virulence of NDV. 
 
These studies indicate that by eliminating certain glycosylation sites found on the 
HN glycoprotein of NDV, attenuated NDV strains can be engineered. This approach can 
be used to generate improved recombinant vaccines for controlling Newcastle disease in 
poultry. It would be interesting to evaluate the effects of glycosylation on the functional  












5.1  Title  
 





The recent report of the crystal structure of the globular head of the 
hemagglutinin-neuraminidase (HN) protein of Newcastle disease virus (NDV) has helped 
in the location of a number of residues that are predicted to form the receptor-recognition 
and neuraminidase active sites. A site-directed mutagenesis procedure was adopted to 
change these amino acid residues near the active site in the HN protein of Beaudette C, a 
virulent strain of NDV. These residues were made similar to the ones present in LaSota, 
an avirulent strain of NDV. The role of these residues in the functional activity of NDV 
was assessed by measuring hemadsorption, neuraminidase and fusion activities. The 
importance of these sites in the virulence and infectivity of the virus was assessed with 
the mean death time (MDT) study in 9-day-old embryonated eggs. Our results indicated 
that the residue R416 is important in receptor-recognition and neuraminidase activities 
and residues E495 and N568 play a role in fusion promotion activity of the HN protein. 
These studies also show the importance of these sites in virus infectivity and virulence.  
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5.3  Introduction 
 
The HN protein of NDV is a type II homotetramer  glycoprotein. It is a 
multifunctional  protein and is responsible for receptor-recognition by binding to sialic 
acid receptors on host cells. It also acts as a neuraminidase and cleaves virus from 
infected cells, by hydrolyzing sialic acid from progeny virion particles, thus, preventing 
viral self-agglutination. Finally, it helps in fusion by specifically interacting with the 
fusion protein of NDV (71, 121, 122). The HN protein of NDV consists of a 26 amino 
acid amino-terminal cytoplasmic domain and a 22 amino acid transmembrane domain 
(88). The ectodomain of the HN protein consists of a 95 amino acid long stalk, 
supporting a 428 amino acid terminal globular head, which contains the receptor 
recognition, neuraminidase (NA) and antigenic sites (86, 142). The recent report of the 
crystal structure of the globular head of NDV throws tremendous light on the location of 
the sites active in receptor recognition, NA and fusion promotion activities (24). Previous 
studies have proposed conserved residues R174, I175, D198, K 236, R416, Y526 and 
E547 as being important in receptor recognition and NA activities and residues R174 and 
E547 to influence the fusion promotion activity of the HN protein of NDV (23).  
Although, mutations in the transmembrane and stalk regions of the HN protein can affect 
the activities of the protein (79, 139), the ectodomain region of the HN protein of NDV is 
thought to play a key role in influencing virus infectivity. All of the antigenically and 
functionally important residues in HN are localized in the globular head (142).  
Therefore, our goal was to examine the role of certain key amino acid changes in the 
globular head region.   Comparisons of the HN protein sequence between LaSota and BC 
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viruses identified only 17 amino acid differences.  Three of the amino acid differences 
were in the transmembrane domain, two were in the stalk region, and twelve of the 
differences were in the globular head region.   In this study besides examining the role of 
the conserved residue R416 (found near the sialic-acid binding site of the HN protein of 
NDV), in the biological activities of the HN protein of NDV, we also examined certain 
residues (I219, S494, E495 and N568), which were different between a avirulent strain of 
NDV, LaSota and a virulent strain of NDV, Beaudette C (BC). Examination of the amino 
acid changes using the HN crystal structure showed that residues T214, I219 and N568 
are in the region where mutations resulted in a decrease or an abolition of fusion 
(personal communication, Dr. Allen Portner, St. Jude’s Children Research Hospital, 
Memphis, TN).  Two other amino acids, S494 and E495 are also in close proximity to 
this region.  
 
We tested the effect of the mutations done on these residues in virus infectivity by 
in vitro and in vivo assays. The growth characteristics, neuraminidase, hemadsorption and 
fusion activities of the mutant viruses were compared with those of the parental BC virus.  
  
Our results indicate the importance of the residue R416 in hemadsorption and NA 
activity and virus infectivity, thus, influencing NDV virulence. Fusion promotion activity 
of viruses with mutations at residues E495 and N568 was also altered indicating the 
importance of these sites in fusion promotion. Identification of specific sequences 
involved in virulence will give insights into the mechanisms involved in NDV 
pathogenesis.   
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5.4 Materials and Methods 
 
5.4.1  Cells and Virus 
DF1 cells were maintained in DMEM  and Vero and HEp2 cells were maintained 
in EMEM media. NDV strain, Beaudette C (BC) was received from the National 
Veterinary Services Laboratory, Ames, IA. The virus was propagated in the allantoic 
cavity of embryonated chicken eggs and the virus was purified from the allantoic fluid as 
described previously (Chapter 3). 
 
5.4.2 Construction and recovery of active site NDV HN mutants 
Full-length antigenomic cDNA of BC virus was cloned into a low-copy number 
plasmid vector, pBR322 (69). It was designated as pBC. Reverse genetics procedures 
were used to rescue the recombinant virus rBC, as described elsewhere (69). The MluI –
AgeI fragment HN gene from pBC was subcloned into pGEM 7Z(+), as described 
previously in Chapter 4.  Using site-directed mutagenesis (9), a panel of 5 HN mutants 
were generated. All PCR mutagenesis studies were performed using high fidelity pfu 
DNA polymerase (Stratagene).  Based on the specific amino acid residue that was 
mutated, these clones were designated as I219V, R416Q, S494G, E495V, and N568D. 
The amino acid residues 219, 494, 495 and 568 present on the mesogenic BC HN protein 
were mutated into the corresponding amino acid residues found on the HN protein of the 
lentogenic LaSota virus. Sequence analysis of the HN protein of BC and LaSota viruses 
revealed that the amino acid residue 416, present near the active sialic-acid binding site 
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(23) was similar in both the viruses.  The residue R416 was mutated to glutamine (Q) to 
study the effect of the mutagenesis on the biological activities of the HN protein and on 
viral infectivity. Listed below are the set of primers used to mutate the BC HN cDNA 
clone, resulting in the generation of 5 HN mutagenized clones in the PGEM 7Z (+) 
vector. Bold and italicized alphabets represent mutated nucleotides present on the HN 
gene of BC:  
HN 219 5′ GTCTTCTTTTCTACTCTGCGTTCC 3′ 
HN219/R 5′ CCTCCCTGTTGCAGTTGTCCG 3′ 
HN 416 5′ CAGGGGTCATCATACTTCTCT 3′ 
HN416/R 5′ CTGATACAAGAAATGAGATGTCCC 3′ 
HN 494 5′ GGAGAACAAGCAAGAC 3′ 
HN 494/R 5′ ATCAAGCATTGTCCCGAATACC 3′ 
HN 495 5′ GTGCAAGCAAGACTTAATCC 3′ 
HN495/R 5′ ACTATCAAGCATTGTCCCGA 3′ 
HN 568 5′ GACGATGGGGTTAGAGAAGCCAGG 3′ 
HN 568/R 5′ TTTGAGGATCTCAACTAGTAACGGG 3′ 
 
All the mutated HN genes were sequenced entirely before introducing into the 
full-length NDV cDNA clone. Each mutagenized HN gene was then inserted into the 
full-length BC cDNA clone (pBC). These full-length cDNA clones were transfected into 
HEp2 cells and 5 mutant viruses were recovered using the recovery procedures 
mentioned earlier (69). Based on the HN mutagenized clones I219V, R416Q, S494G, 
E495V, and N568D, the recovered recombinant viruses were called rI219V, rR416Q, 
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rS494G, rE495V, and rN568D, respectively. The mutant HN gene in each of the 
recovered viruses was sequenced by RT-PCR to confirm the presence of the substituted 
amino acid.   
 
5.4.3 RNA extraction and RT-PCR of recovered chimeric viruses  
The recovered recombinant were grown in the allantoic cavity of 9-day-old 
embryonated chicken eggs. After 2 days, the allantoic fluid was harvested and clarified 
and virus was purified as described previously. Viral RNA was extracted from the 
recovered viruses using TRIzol (Invitrogen, USA), according to the manufacturer’s 
instructions. Reverse transcription was done with the extracted RNA, using the 
Thermoscript RT kit (Invitrogen, USA) to synthesize the first strand cDNA. The genomes 
of recovered chimeric viruses were entirely sequenced after RT-PCR to confirm the 
presence of the substituted gene.   
 
5.4.4 Growth characteristics of HN mutant viruses 
The growth kinetics of the recombinant HN mutant viruses were performed by 
multi-step growth curves in DF1 cells. The viruses were inoculated to confluent 
monolayers of DF1 cells at a m.o.i. of 0.01. Supernatant was collected at 8 h intervals 
until 56 h post infection (P.I). The virus titer in the cell culture supernatant was assessed 





5.4.5 Biological functions of recombinant viruses 
Biological functions of the recovered viruses were assessed by hemadsorption, 
fusion and neuraminidase assays. These were done as described earlier in Chapter 3.  
 
5.4.6 Mean Death Time (MDT) in chicken embryos  
The virulence of the recovered viruses was determined by the mean death time (1) 
in embryonated SPF chicken eggs. A series of 10-fold dilutions of infected allantoic fluid 
was made in sterile PBS, and 0.1 ml of each dilution was inoculated into the allantoic 
cavity of each of the five 9-day old embryonated eggs. The eggs were incubated at 37oC 
and examined four times daily for 7 days. The time that each embryo was first observed 
dead was recorded. The highest dilution at which all embryos died was considered the 
miimum lethal dose. The MDT was recorded as the mean death time in hours for the 
minimum lethal dose to kill the embryos. The MDT has been used to classify NDV 
strains into velogenic (taking under 60 h to kill); mesogenic (taking between 60 h to 90 h 






5.5.1 Construction of HN mutant cDNAs and recovery of mutant viruses 
The recovery of recombinant NDV from infectious cDNA clones, derived from a 
mesogenic strain of NDV, BC, and a lentogenic NDV strain, LaSota, have been reported 
earlier from our laboratory (54, 69). In this study, we used the established reverse 
genetics system to examine the role certain key amino acids present in the globular 
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ectodomain (Fig.19) of the HN protein in the biological activities of the HN protein and 
in the virulence of NDV. A cDNA subclone of the HN gene (MluI-AgeI fragment) of 
NDV strain BC was used for site-directed mutagenesis to generate five HN mutant 
clones. Each of the mutagenized HN gene was then inserted into a full-length cDNA 
clone of BC, thus generating five full-length BC cDNA clones carrying the specific HN 
mutations. NDV strain BC HN amino acid residue I219 isoleucine (ATA) was mutated to 
valine (GTC), R416 arginine  (CGA) to glutamine (CAG), S494 serine (AGT) to  
glycine (GGA), E495 glutamic acid (GAA) to valine (GTG)  and N568 asparagine 
(AAT) to aspartic acid (GAC). Each amino acid residue was changed by mutating at 
least two of its nucleotides to ensure the stability of the mutation and to prevent the 
mutation from reverting back to the original residue. Based on the amino acid residues 
mutated on the HN protein of BC, the cDNA clones were designated as I219V, R416Q, 
S494G, E495V and N568D (Fig. 20). To ensure the presence of the intended mutations, 
the entire HN gene from each of the full-length cDNA clones was sequenced using Big 
dye terminator (Applied Biosystems) method.  Each full-length cDNA clone was used for 
transfection and recovery of a HN mutant virus using reverse genetics procedures (69). 
The supernatants from transfected HEp2 cells were passaged two times in DF1 cells to 
recover infectious NDV. Virus-positive supernatants were used to inoculate the allantoic 
cavities of 9-11-day-old embryonated SPF eggs. The allantoic fluid harvested after 
embryo deaths were analyzed in a hemagglutination (HA) assay. Allantoic fluid with a 
positive HA titer was used for the isolation of viral RNA, followed by a sequence  
analysis of an RT-PCR fragment that covered the mutated HN gene region. Nucleotide 















Figure 19. Three-dimensional structure of the HN protein monomer derived from the 
crystal structure of NDV HN reported by Crennell et al. (24) showing location of key 
amino acid residues (in orange) involved in the biological activities of the HN protein.  
These locations were predicted using the Acceryls Viewer Pro 4.2 software. The central 
region (amino acids in yellow) is the active site for receptor binding and neuraminidase 
activities as reported by Crennell et al. (24). Glycosylation sites are indicated by amino 




















Amino acid        Beaudette C     LaSota       Mutant  
 
 
219                         I                 V             I219V 
 
494                         S                G             S494G 
                      













Figure 20.  Schematic representation of  the generation of HN mutants in the globular 
head region of HN of NDV. The numbers in the figure and table represent the amino acid 
residues that were mutated using site-directed mutagenesis on a cDNA clone of the HN 
gene of the NDV strain Beaudette C (BC). Amino acids 219, 494, 495 and 568 were 
changed on the BC HN clone to the corresponding amino acids present in the HN gene of 
NDV strain LaSota. Amino acid residue 416 which is the same in LaSota and BC was 
mutated to a different amino acid.  
 






The recovered recombinant viruses were designated as rI219V, rR416Q, rS494G, 
rE495V, and rN568D. The HN mutations in these viruses were stable and were seen even 
after ten sequential passages of these viruses in DF1 cells (data not shown). 
 
 
5.5.2 Growth of the recombinant viruses in vitro 
The growth characteristics of the parental and HN mutant viruses were assessed by multi-
step growth curves (Fig. 21). The differences in the growth kinetics of only the HN 
mutant R416Q was markedly different form the parent BC virus. The growth rate of the 
recombinant virus R416Q  was two-fold lower  than the BC virus during time points 8 
and 16h PI.  After 20h PI the R416Q virus titers were comparable to its parental BC virus 
titers. All other HN mutant viruses grew to titers similar to that of the BC virus at all time 
points.  For comparison the titers of LaSota virus is also shown in the figure. These 
studies showed the relevance of the amino acid residue R416 at the active site of the HN 





























































Figure 21. Growth kinetics of HN mutant viruses in tissue culture. Multicycle growth of 
parental and HN glycosylation mutant viruses in chicken embryo fibroblast (DF1) cells.  
Cells were infected at an MOI of 0.01 with the indicated parental or chimeric virus. 
Samples were taken at 8h intervals and virus titers were determined by plaque assay.  











5.5.3 Biological activities of HN mutant viruses 
We analyzed whether the mutations in the HN protein modulated the biological 
activities of NDV. The NA, HAd and fusion activities of the parental and HN mutant 
viruses are shown (Fig. 22A).  The percent biological activity of each virus is shown 
relative to the rBC virus, whose biological activities were considered to be 100%. The 
HN mutant virus R416Q had the most significant differences in the NA, HAd and fusion 
promotion activities when compared to its parent rBC virus. The NA value of rR416Q 
was less than 10% of rBC virus and its HAd activity was only 20% of rBC. Its fusion 
promotion activity was only 50% of the parental rBC virus.  The HN mutants I219V, 
S494G, E495V, and N568D did not have significant differences in their NA and HAd 
activities when compared to the BC virus. Fusion promotion activities of E495V (65% of 
BC), and N568D (approximately 75% of BC) mutant viruses were diminished when 
compared to the BC virus. (Fig. 22B). The fusogenic ability of the HN mutant viruses 
I219V and S494G did not vary significantly from that of rBC virus. These studies 
emphasize the importance of mutations in certain key amino acid residues on the HN 
protein in the attachment and neuraminidase functions of NDV in the context of a viral 
infection. These differences in the attachment and elution may translate into differences 



















































































































        
 
Figure 22A. Biological activities of the HN mutants. The hemadsorption (HAd), 
neuraminidase (NA) and fusogenicity of HN mutants were examined. HAd was measured 
as the percentage of the hemoglobin released compared to the parental rBC virus. The 
NA activities and fusion indices (FI) of the mutant viruses were also shown in 
comparison with these activities of the rBC virus. NA activity of purified viruses was 
measured by a fluorometric assay. The FI is the ratio of the total number of nuclei to the 
number of cells in which the nuclei were observed (i.e., the mean number of nuclei per 
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igure 22B. Fusion of HN mutants.The fusogenicity of the mutant viruses in Vero cells 
in comparison to the parental rBC virus. Infected cells were fixed at 48h post-infection 
and stained with hematoxylin-eosin. The extent of fusion of the parental rBC (a) and the 
mutant viruses rI219V, rR416Q, rS494G, rE495V, rN568D and rLaSota (b, c, d, e, f, and 
g) in Vero cells are captured at 200X magnification in a Nikon Eclipse TE 300 
microscope. Uninfected Vero cell monolayer (h) is included as a negative control for 
comparison. 






5.5.4 Pathogenicity studies of HN mutant viruses 
  To determine whether the differences in in vitro biological characteristics of the 







ic viruses would translate into increased or decreased 
em s in vivo, the mean death time (MDT) pathogenicity test was carried out with the 
recovered recombinant HN mutant viruses (Table 5).  The HN mutant virus rR416
70h to kill 9-day-old chicken embryonated eggs, which was longer than the time taken by
the parental BC virus (62h). This indicated a loss of virulence of the R416Q virus in vivo. 
These results corroborated with the in vitro growth characteristics and biological 
activities of the R416Q virus.  The MDT of the I219V virus was 60 h, S494G virus was 




































able 5. HN mutants of NDV and virus pathogenicity in vivo.  
he viru ce of the mutant and parental v ruses was evaluated by intracerebral 
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six-week-old chickens, and mean death time (MDT) in eggs. a MDT in hours for 
minimum lethal dose to kill 9-day-old embryonated chicken eggs by allantoic route of 
inoculation.  









The MDT of the avirulent NDV strain LaSota was 96h.  None of the mutant viruses took 
s long as the LaSota virus to kill the embryos indicating that virus infectivity in vivo is a 
 
5.6 Discussion  
 
NDV is a multifunctional spike protein, which serves as the 




N protein in 
esidue to 
a
multifactorial phenomenon. Although mutating key amino acids residues such as R416 
present at the receptor-binding site of the HN protein, has significant effects on the 




The HN protein of 
motion activities (71). A recent report of the crystal structure of the globular hea
region of the HN protein of NDV has provided important clues about the location o
receptor binding and the sialic acid binding sites, (otherwise known as the “active site”
present on the HN protein (24). For the initiation of fusion promotion activity of the HN 
protein, a type-specific functional interaction between F and HN proteins of 
paramyxoviruses is required (53). Studies of hybrid HN proteins by three different 
laboratories have all implicated the membrane-proximal ectodomain of the H
virus-specific fusion promotion activity (31, 141, 144). In an attempt to study the 
importance of specific amino acid residues present at the active site of the HN protein, on 
the virulence of NDV, we performed the following study. Using site-directed 
mutagenesis, on a cDNA clone of BC (a mesogenic strain of NDV), amino acid residue 
R416 present at the active site of NDV was mutated by changing the arginine r
glutamine. Mutational analysis of certain other amino acid residues (219, 494, 495, and 
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568) present near the active site of the HN protein of BC was also carried out. These 
amino acid residues are different in BC when compared to the corresponding amino acid
residues present in the HN protein of an avirulent NDV strain LaSota. We mutated the
amino acids present in the HN protein of a virulent NDV strain BC, to the ones present in 
an avirulent NDV strain LaSota to examine the role of these residues in modulating 
virulence of  the virus. Using reverse genetics procedures (69) five mutant viruses were 
recovered and the HN gene of each recovered virus was entirely sequenced to ensure
presence of the intended mutations. These mutations were stable after ten sequential 
passages of the recovered viruses in tissue culture cells and one passage in 9-day-old 
chicken embryonated eggs. The effect of these mutations on the biological activities o
the HN protein of each mutant virus was evaluated with hemadsorption, neuraminidas
and fusion promotion studies in vitro. The effect of the mutations on virus infectivity in 
vivo, was studied by infecting 9-day-old embryos with each of the mutant viruses and 
recording the time taken for each virus to kill the embryos (mean death time study). The 
most significant finding of this study was the near abolition of the hemadsorption and 
neuraminidase activities of the R416Q mutant. This reflected its important role in virus 
attachment and neuraminidase activity. This mutant was also less virulent when 
compared to the parental BC virus as indicated by the MDT study. The mutant R416Q 
took 70 hours to kill the infected 9-day-old embryos (as opposed to 62 hours take
parental BC virus), to kill the embryos. Another interesting finding was the role of 
residues E495V and N568D in fusion promotion activity of the HN protein. These 
mutants exhibited lower rates of fusion promotion when compared to the parental B










different from the BC virus. In vivo studies (MDT) with these mutants did not reveal an
significant difference from the parental BC virus in viral infectivity. These residues may 
play a role in modulating fusion promotion activity of the HN protein of NDV. It will be 
interesting to create mutant viruses with multiple mutations of such key amino acids and 
study the combined effect of these mutations on viral infectivity. This can be done by 
incrementally placing additional amino acid changes into the original mutant viruses and 
testing the infectivity of the virus in vitro and in vivo. Besides the residue R416, the oth
amino acids forming the triarginyl cluster at the receptor-binding domain of the HN 
protein are residues R174 and R498 (23). Residues E401 and Y526 have been reported 
by Connaris et al, to be important for receptor binding (23). To test the effect of 
mutations of these amino acids on virus infectivity, further studies are being carried out.
Although the amino acid changes in and around the active site pocket or on the o
surface of the HN molecule are important to the functions of the protein, the amino acid 
changes in other areas of the protein can also have an indirect effect on the functions o
the protein.  Comparisons of the HN protein sequence between LaSota and BC viruses 
identified only 17 amino acid differences. Therefore, we plan to examine the role of all o
the amino acid differences using a chimeric approach. To find out whether virulence 
determinants lie in the globular head, stalk or transmembrane regions of the HN protein, 
chimeric viruses can be constructed using these regions of the HN gene of virulent an
avirulent NDV viruses. With these studies we will be able to better understand of the 











CHAPTER  6 
 
6.1 Title 
Conclusions and prospects 
 
6.2 Conclusions and Prospects 
 
Newcastle disease is a highly contagious and fatal viral disease that affects all 
species of birds. It is an economically important avian virus that can cause huge 
economic losses to the poultry industry (2). The causative agent of the disease is the 
Newcastle disease virus (NDV). NDV is an enveloped, negative-sense, single stranded 
RNA virus, belonging to the Paramyxoviridae family and genus Avulavirus (78, 89). The 
Paramyxoviridae  family also includes other important pathogens such as the mumps 
virus, human parainfluenza virus, sendai virus, simian virus 5 and recently emerging 
nipah and hendra viruses. Nipah and hendra viruses may prove to be agents of 
bioterrorism (50). Highly virulent strains of NDV have been categorized as potential 
agents for agroterrorism (51). Understanding the molecular biology and molecular basis 
for pathogenesis for these viruses is thus, of great importance.  
 
Results from the various studies done in this project indicate the importance of the 
HN protein of NDV in virus pathogenesis. By exchanging the HN gene between virulent 





roduction of infectious RNA 
irus entirely from cloned cDNA. Using this system, genetic manipulation of RNA viral 
genome h help 
ics 
 
tropism and NDV virulence. Further studies were done using site-directed 
mutagenesis, to eliminate each of the functional glycosylation sites on the HN protein of 
NDV. This investigation indicated that glycosylation sites of the HN protein play an 
important role in modulating NDV pathogenesis. We also explored the importance of 
certain key amino acid residues in the globular head ectodomain of the HN protein with a 
mutational analysis approach. The study indicated the key role of some of these residues 
in the biological activities of the HN protein and in influencing NDV pathogenesis. These 
studies provide the basis for further investigations to understand the overall role of the 
HN protein in NDV virulence. It will be interesting to study the molecular mechanism by 
which the HN gene determines tropism and virulence.  
 
Reverse genetics techniques have revolutionized the study and molecular 
understanding of RNA viruses. This procedure allows p
v
s at the cDNA level can be done. Studies with this plasmid-based approac
in introducing defined mutations anywhere in the cDNA genome and studying their 
effects on characteristics of the generated recombinant virus. Although live, attenuated 
virus vaccines against NDV are available currently, the need for a more stable and 
efficacious recombinant vaccine is still in demand. With the help of the reverse genet
system, we have investigated the role of the HN protein in NDV pathogenesis. Since HN
is a multifunctional protein of NDV, which is actively involved in virus infectivity, 
studying the role of the HN gene in virus pathogenesis is important to understand the 
basis for molecular pathogenesis of the virus.  The HN protein is the main target of 
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immune response for NDV (82, 87). Since HN possesses immunogenic properties, fu
studies on this protein may prove to be useful for the development of NDV vaccines.  
 
With the current study on the HN protein of NDV, we could generate an 
attenuated virus by abolishing glycosylation site 4 and sites 1 and 2 in combinat
rther 
ion 
hapter 4). Additional studies on the HN protein may pave the path towards generation 
of an a
s antineoplastic agents. Recent research (152) has 
shown that the HN protein of NDV may be responsible for induction of interferon-alpha 
and tum
(C
ttenuated recombinant NDV vaccine. The introduction of reverse genetics system 
to the molecular biology of NDV has opened several doors in the development of 
recombinant NDV vaccines. Generation of a recombinant chimeric HN vaccine that 
allowed serological differentiation between vaccinated and infected animals has been 
reported (107). Recombinant NDV has also been used as a vaccine vector (95). 
Identification of specific sequences in the HN protein responsible for NDV virulence will 
give insights into the mechanisms involved in NDV pathogenesis. With the availability of 
an established reverse genetics system for avirulent and virulent NDV strains, it would be 
of special interest to study the importance of various regions of the HN protein in NDV 
virulence using a chimeric approach.  
 
Molecular biology studies of the NDV HN protein of NDV should also prove 
useful in the development of NDV a
or necrosis factor-related apoptosis. Promising results on using NDV as an 
antitumor agent have already been shown in many clinical trials (25, 96,124). NDV 
possesses many qualities that make it an excellent antineoplastic agent. It has good cell-
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binding properties, it binds specifically to tumor cells, it replicates only in tumor 
cytoplasm, and it is relatively safe (99, 125). A more detailed study of the HN protein 
may thus provide some insights into use of NDV in cancer therapy.  
 
Previous research has indicated a strong and definitive interaction between the F 
and HN protein of NDV in initiating and influencing extent of viral infection (138).  It 
would be interesting to exchange both F and HN proteins between virulent and avirulent 
NDV v
und in nature 
which cause a continuous spectrum of disease in birds, ranging from inapparent to fatal 
disease
iruses to study the effect of this swap in viral pathogenesis. Since HN is an 
immunogenic protein, it would also be intriguing to include an additional HN gene of 
NDV into the full-length DNA genome of NDV and studying the effect of this gene 
addition in viral immune response. Insertion of a foreign gene into NDV cDNA has been 
reported earlier (69). Also, generation of chimeric HN viruses would throw more light on 
the role of specific domains of the HN protein in NDV virulence. Another interesting 
area to explore would be the importance of the glycosylation sites of the F protein in 
virus infectivity. Armed with the knowledge of basic studies on the virus, genetically 
stable live attenuated NDV viruses can be made for vaccine development.  
 
NDV can be used as an ideal model for understanding the molecular basis of 
pathogenesis of other paramyxoviruses, since various NDV strains are fo
. Moreover, the experiments involving the study of pathogenesis of NDV can be 
carried out directly in chickens, the natural hosts of NDV.  
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A deeper understanding of NDV molecular biology may not only be applied to 
the control of Newcastle disease but may also be exploited to understand the molecular 
biology and basis of pathogenesis for other paramyxoviruses, many of which are 
hazardous to human health and well being. Identification of viral factors and molecular 
mechanisms involved in NDV pathogenesis will enhance our understanding in 
paramyxoviruses in general. Future work with NDV will also be applicable to the study 
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